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Vulnerability and robustness in the essential gene complement of two bacterial species, 
profiled with CRISPRi 
Melanie R. Silvis 
 
ABSTRACT 
 
 Bacterial essential genes contribute to the most fundamental processes of cellular life. 
The study of their functions in vivo has long been intractable to systematic genetic approaches, 
which are fundamental to understanding pathway level connections that govern cellular life and 
are a requirement for dissecting the complex cellular processes to which essential genes 
contribute. In Chapter 1 of this work I review recent advances in mapping gene-phenotype 
relationships in bacteria using the CRISPR-based technology, CRISPR interference (CRISPRi) 
for titratable gene knockdowns, focusing on their applications to the studies of essential genes, 
the exploration of chemical-genetic interactions, and the prospects for disentangling complex 
phenotypes in diverse bacterial species. In Chapter 2 I describe my analysis of the essential 
gene functions in the model Gram-negative bacterium Escherichia coli and the model Gram-
positive Bacillus subtilis using datasets from paired chemical-genetic screens. In this work I 
identify both shared and Gram-negative specific mechanisms of collateral sensitization to 
antibiotic action. In Chapter 3 I investigate a fundamental property of essential genes, which is 
the relationship between their expression level and the cellular growth rate. Here, further 
developing CRISPRi tools in bacteria to predictably titrate knockdown efficacy, I interpret the 
knockdown-fitness relationships of each essential gene in E. coli and B. subtilis, discovering 
broad conservation of constraints setting and maintaining expression levels across these 
diverged species.  
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Chapter 1 
Introduction 
  
 2 
INTRODUCTION 
Bacteria must protect their genetic material from invasive DNA elements such as phages 
and plasmids, and they accomplish this using diverse immune systems (Bernheim and Sorek 
2019) that are tasked with both recognition and response to these molecularly simple foreign 
agents. The mechanisms of these two activities—recognition and the protective responses—
have provided a bountiful source of inspiration for technological development with applications 
in diverse areas including basic research, diagnostics, and therapeutics (Knott and Doudna 
2018; Pickar-Oliver and Gersbach 2019; C. H. Huang, Lee, and Doudna 2018; Y. Li et al. 2019). 
CRISPR immunity systems, arguably the category of bacterial immune systems with the most 
penetrance in recent technological development, couple programmable sequence-specific 
recognition with specified nuclease activities, using either multi-protein or single-effector 
complexes (Hille et al. 2018). Importantly, these systems are highly modular, enabling them to 
be easily ported into different contexts while retaining their targeting and nuclease activities, and 
are often amenable to combination with other enzymes or mutation in order to expand their 
functionalities. 
  A major driver of CRISPR-based technology development is their application in 
functional genomics: coupling genome-scale genetic perturbations with high-throughput 
phenotypic assays to systematically define gene-phenotype relationships. Microbial genomes 
are a major source of new gene content and functionalities. As the pace of bacterial whole-
genome sequencing increases, higher-throughput functional assays must be developed to link 
the identification of novel genes and their products with their cellular roles. CRISPR-based tools 
are poised to bridge the gap between genotype and phenotype, and this review will focus on 
CRISPR interference (CRISPRi) approaches for bacterial gene knockdown. CRISPRi offers 
three specific features that will enable rapid genotype-phenotype associations: (1) it enables 
rapid construction of genome-scale barcoded libraries of pre-programmed gene knockdowns, 
(2) CRISPRi can reduce gene expression to intermediate levels (i.e. not “all or nothing”), 
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allowing the investigation of intermediate phenotypes with specific implications for the essential 
genes, and (3) CRISPRi tools have now been demonstrated to function in diverse microbial 
species, allowing gene functions to be studied across large evolutionary timespans. 
In this review we will discuss recent developments in the application of CRISPRi to 
generate libraries of unique genetic perturbations in bacterial systems of interest, and their 
applications in characterizing gene function. In the process, we will highlight both technological 
and conceptual advances in functional genomics that are afforded by these new scalable 
technologies. 
  
CRISPR interference (CRISPRi) for targeted gene knockdown in bacteria 
The twin roles of CRISPR immunity systems—recognition and nuclease activity—are 
productively uncoupled in CRISPR interference (CRISPRi) approaches, that use nuclease-
inactive effector proteins which retain the ability to stably bind their target DNA, enabling their 
use as programmable transcriptional repressors. In this section we will review the initially 
described features of bacterial CRISPRi and how recent comprehensive analyses have 
provided a more detailed picture that will influence how large-scale functional studies are 
designed and interpreted. 
  To date, the majority of bacterial CRISPRi applications have built on early work using a 
catalytically inactive mutant of the Type II-A Cas9 system from Streptococcus pyogenes 
(dCas9Spy) for programmable repression in Escherichia coli (Qi et al. 2013; Bikard et al. 2013). 
Natural Type II systems consist of a single effector protein (Cas9) which is targeted to DNA by 
the sequence of the spacer region in a two-RNA duplex. In these first concurrent 
demonstrations of bacterial CRISPRi, the two-RNA duplex was supplied using either the natural 
configuration of crRNA:tracrRNA (Bikard et al. 2013) or using a simplified single chimeric 
sgRNA (Qi et al. 2013), in either case the spacer region being easily modified to determine the 
targeted locus. Binding of the dCas9-sgRNA complex to DNA involves a two-part recognition 
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mechanism, one carried out by each member of the complex (Sternberg et al. 2014; Szczelkun 
et al. 2014). First, dCas9 recognizes a short, double-stranded DNA sequence called the 
protospacer adjacent motif (PAM) which is identified by 1D diffusion scanning along DNA 
stretches. Second, the DNA duplex adjacent to the PAM is unwound as a DNA:RNA hybrid is 
formed between the sgRNA spacer region and the target DNA strand. Once the dCas9-sgRNA-
DNA complex and 20bp R-loop is formed it is extremely stable, exhibiting off-rates on the order 
of ~6hr in mammalian cells (Richardson et al. 2016) and the complex is hypothesized to only 
undergo dissociation events in bacterial systems following DNA replication cycles (Jones et al. 
2017). 
  In the initial work establishing bacterial CRISPRi, several important properties of 
CRISPRi were characterized that have, in most cases, been borne out in subsequent 
comprehensive studies. Each of these properties influence the design and interpretation of 
CRISPRi libraries for use in functional genomics. 
  First, the initial work outlined two mechanisms by which CRISPRi can function in 
bacteria. When targeted to promoter regions, dCas9-sgRNA complexes prevent RNAP 
recognition and therefore transcription initiation. Alternatively, when targeted within gene open 
reading frames (ORFs), dCas9-sgRNA binding is sufficient to prevent RNAP elongation, as 
assayed by NET-seq (Churchman and Weissman 2011) in now two species (Qi et al. 2013; 
Peters et al. 2016). The latter mode is more commonly employed in bacterial CRISPRi screens 
to date, and has the advantages of not requiring TSS annotation (Lee et al. 2019) and having 
increased target space within ORFs as opposed to promoter regions. 
Efficacy of knockdown when targeted within ORFs shows clear strandedness. sgRNAs 
designed to base pair with the non-template (coding) strand are more effective than those 
designed to base pair with the template (non-coding) strand, and this has been repeatedly 
shown across species (Peters et al. 2016; Lee et al. 2019; Cui et al. 2018). The molecular 
mechanism explaining this strandedness is not known, however recent in vitro work has shown 
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that template-strand targeted dCas9-sgRNAs are more easily surpassed by both bacterial multi-
subunit RNAPs and by phage single-subunit RNAPs than non-template targeted complexes 
(Widom et al. 2019), suggesting this pass-through property is common across diverse RNAPs. 
Again, most functional genomics approaches using CRISPRi in bacterial systems now 
exclusively use non-template targeting sgRNAs, though some benefits to exploring weak 
perturbations using template-targeting sgRNAs have been discussed (Rousset et al. 2018). 
Although early work with small numbers of sgRNAs suggested that efficacy of repression 
by targeting dCas9-sgRNA complexes within ORFs was location-dependent—targeting 5’ within 
the ORF having a stronger effect than targeting towards the 3’ end (Qi et al. 2013)—more 
comprehensive analysis with larger numbers of sgRNAs has found no significant difference in 
repression, by assaying either expression (protein level) (Hawkins et al. 2019) or indirectly by 
assaying fitness of essential gene knockdowns (Wang et al. 2018). The relatively consistency of 
effects from targeting different loci within the same gene (Hawkins et al. 2019) have lent support 
to analytical approaches that use a synthesis of the measurements from multiple sgRNAs 
targeting the same gene (discussed further below). 
Bacterial genes are often organized into clusters (operons) that are co-transcribed, and 
because CRISPRi acts by interfering with transcription elongation the potential to interfere with 
the expression of neighboring genes is a central concern that continues to be explored. Early 
work conceptualized these effects in two distinct categories: the expression of genes 
downstream of the targeted gene was anticipated to be reduced as elongating RNAP were 
stalled before reaching their ORFs (CRISPRi “forward polarity”), and by an incompletely 
understood mechanism genes upstream of the targeted gene were frequently observed to be 
repressed (CRISPRi “reverse polarity”). Both forward and reverse polarity were shown to 
function in B. subtilis using a synthetic rfp-gfp operon, with forward polarity having a stronger 
effect than reverse polarity (Peters et al. 2016). These data support the conclusion that bacterial 
CRISPRi can provide operon-level functional classification. 
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Both forward and reverse polarity have been challenging to employ as assumptions in 
functional analysis. First, forward polar effects from targeting non-essential genes upstream of 
essential genes have comprised a relatively low percentage of false positives in essential gene 
assignments using CRISPRi in E. coli (Wang et al. 2018; Rousset et al. 2018), highlighting 
incomplete knowledge of transcription unit organization even in well-studied species. Second, 
comprehensive descriptions of reverse polar effects have been similarly case-by-case, with a 
more general position-dependent effect when targeting within 50bp of the ends of upstream 
genes, and a small number of cases seeming to cause reverse polarity for targeting at any 
position (Wang et al. 2018). 
         Almost certainly there are multiple layers occluding the underlying phenomenon in these 
reports. The first is that it has been traditionally easiest to measure the effects of targeting up- or 
down-stream of essential genes on fitness as a proxy for polar effects on transcription, or by 
using synthetic operons of fluorescent proteins. Each has caveats that may prevent 
generalization. Furthermore, while the (or any) mechanism of reverse polarity is incompletely 
understood, species-specific effects remain a likely source of discrepant results. 
  A third property suggested by early bacterial CRISPRi applications is that targeting in 
bacterial genomes was highly specific. Using RNA-seq, sgRNAs targeting a non-endogenous 
gene (rfp) have been shown to not interfere with endogenous gene expression (Qi et al. 2013; 
Peters et al. 2016; Qu et al. 2019), arguing that targeting specificity is theoretically high in 
relatively small bacterial genomes that have limited off-target sequence potential. At odds with 
these demonstrations, evidence in support of relaxed targeting constraints was also explored 
early on, suggesting that targeting required the PAM sequence and at least 12bp of PAM-
proximal sequence (Qi et al. 2013; Bikard et al. 2013). More recent phenotypic screens have 
further characterized the impact of these relaxed targeting constraints on phenotype 
assignment, identifying multiple cases where off-target effects are a source of false positives, for 
example in identification of genes contributing to fitness (Rousset et al. 2018; Cui et al. 2018). 
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These studies have characterized 9 or 11bp of sequence identity to promoter targeting or non-
template strand targeting (respectively) as sufficient to interfere with expression at an off-target 
site. These findings highlight the requirement of multiple sgRNAs per target gene in functional 
screens to avoid false positives, as targeting specificity is not ensured by the uniqueness of 
23bp (spacer + PAM) in the genome. 
Reconceptualizing these relaxed targeting requirements as an asset to CRISPRi 
approaches, modifications to sgRNA spacers that impact targeting efficacy are emerging as key 
levers by which to predictably tune knockdown and to therefore explore intermediate 
phenotypes. The majority of bacterial CRISPRi approaches have controlled the cellular 
concentrations of dCas9-sgRNA complex to modulate knockdown efficacy, usually by regulating 
the expression of either or both complex members using defined inducible promoters (Qi et al. 
2013; Peters et al. 2016; X. Li et al. 2016; Cui et al. 2018; Rock et al. 2017). This has enabled, 
for example, the exploration of fitness-promoting genes by constructing CRISPRi libraries in 
permissive conditions (dCas9 or sgRNA is not expressed) and experimentation in non-
permissive conditions (dCas9 or sgRNA expression is maximally induced). However, as detailed 
above, perfect complementarity between the 20bp spacer region of the sgRNA and the target 
DNA is not required for gene knockdown, as was appreciated early in the discovery of Type II 
systems (Jinek et al. 2012), and early evidence suggested that intermediate knockdown effects 
could be achieved by deliberately introducing mismatched bases into spacers at precise 
locations.  
The underlying logic of the impacts on dCas9-sgRNA binding by single mismatches 
have now been evaluated in a number of assays, with results in general agreement with a few 
bacterial CRISPRi-specific lessons. A comprehensive analysis of all single-mismatch variants 
targeting gfp in two bacterial species in a CRISPRi assay has shown that the impacts of single-
mismatches can be reliably and precisely predicted by a simple model using only sequence 
features of the spacer region (Hawkins et al. 2019). This comprehensive dataset captured the 
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full range of intermediate efficacies and found that—in agreement with early reports (Qi et al. 
2013)—mismatches in the seed (PAM-adjacent) region had the largest impacts on efficacy, but 
that even PAM-distal single mismatch variants retained measurable activity. Two recent large 
studies of singly mismatched sgRNAs are in general agreement with the results from this 
analysis, highlighting the universal nature of the CRISPRi mechanism. A large dataset of 
dCas9-sgRNA association rates in vitro to diverse DNA substrates (Boyle et al. 2017) showed 
the same seed-region sensitivity to mismatches, but found that sgRNAs were completely 
tolerant of mismatches at the very distal end of the spacer (positions 19-20) in this assay. 
Similarly, in a recent mammalian CRISPRi study, singly mismatched sgRNAs were used to 
repress essential genes and achieve intermediate growth rates (Jost et al. 2019). This dataset—
relating many sequence features of the sgRNA spacer and mismatch identity to growth rate—
was used to develop an elastic net linear regression model capturing a majority of the variance 
in the dataset (r2=0.52 between predicted and measured growth rates). Again, this model 
describes a system in which mismatches at the distal sgRNA end are completely tolerated, in 
agreement with the in vitro association rate measurements. One interpretation of these data is 
that (1) bacterial systems are a very sensitive assay for dCas9-sgRNA binding, in which very 
slow association rates can be captured, perhaps because the effects are amplified by multiple 
dCas9-sgRNA-DNA interactions per cell, and (2) that mechanistic differences in the mammalian 
CRISPRi systems which use KRAB fusions to recruit stable, silencing chromatin modifications 
again reduce sensitivity to small changes in sgRNA efficacy. If true, bacterial CRISPRi systems 
may represent a novel assay for fundamental properties of dCas9-sgRNA-DNA interactions, for 
example in how anti-CRISPR proteins interact with them to prevent binding (Rauch et al. 2017). 
 The potential to predictably tune knockdown via the deliberate introduction of single 
mismatches into sgRNAs opens up many experimental opportunities to systematically 
characterize gene function. Because mismatches are introduced into the spacer which can be 
used as a strain barcode in next-generation sequencing, multiple intermediate levels of target 
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gene knockdown can be assessed within the same pool and the same experiment. Compared 
to titration of knockdown by inducing dCas9-sgRNA complex concentration, some experimental 
and theoretical work has made the case that tuning knockdown efficacy in the latter way is 
prone to noise and dependence on native expression levels of the targeted genes (Vigouroux et 
al. 2018). Instead, the authors provide evidence that tuning knockdown using sgRNAs with 
mismatches between their spacers and the target DNA experiences less noise. While the 
proposed mechanism of this distinction—that RNAP dislodges dCas9-sgRNA complexes when 
sgRNAs are mismatched—remains to be fully supported, in vitro it has been shown that E. coli 
RNAP passes through even fully matched dCas9-sgRNA complexes on DNA ~30% of the time 
and does not dissociate when it reaches the blockade (Widom et al. 2019). This is consistent 
with persistent attempts to pass through even fully matched dCas9-sgRNA-DNA complexes, 
possibly suggested by the observed NET-seq signals of pausing (Qi et al. 2013; Peters et al. 
2016). 
Finally, multiple reports have noted the unsuitability of specific CRISPRi system variants 
for certain bacterial species and characterized some important issues that should be 
incorporated into the design and analysis of CRISPRi screens for gene function. Toxicity caused 
by dCas9 expression has now been identified by multiple groups (Qu et al. 2019; Rock et al. 
2017) as an sgRNA-independent phenomenon, although the mechanism remains unclear. In 
some cases, toxicity is specifically related to the dCas9 variant used (Rock et al. 2017) and 
manifests as generalized sensitivity to stresses. In other cases, toxicity is a function of 
expression level (Qu et al. 2019). High levels of expression of dCas9-sgRNA complexes have 
also been shown to have sequence-specific toxicities in E. coli (Cui et al. 2018), suggesting that 
it is not the translation load alone that can interfere with normal cell physiology. Users of 
CRISPRi to investigate genotype-phenotype relationships must clearly avoid and control for 
possible non-specific phenotypes, which can be addressed, for example, by evaluating large 
numbers of non-targeting sgRNAs. 
 10 
CRISPRi and assays for gene function 
CRISPRi has to date been used to explore bacterial gene function in two primary modes, 
and almost exclusively in model species. In the first mode, relatively small arrayed CRISPRi 
libraries (<500 sgRNAs) are constructed and deeply phenotyped using relatively low throughput 
quantitative assays. This has been optimally applied for “systems biology approaches”: 
simultaneously capturing the networks of functional interactions between targeted genes by 
quantifying large numbers of independent phenotypes. In the second type of approach, 
advances in parallel oligo synthesis strategies enable the construction of large pooled libraries 
(>30,000 sgRNAs) which are phenotyped in a more limited manner. These works have been 
more in line with “functional genomics”: addressing targeted questions about the contributions of 
individual genes to a specific process, usually one that is linked to growth or fitness. Forward-
looking strategies will likely capitalize on the benefits afforded by each (including development 
of bespoke phenotypic assays for pathways of interest), aim to increase the throughput for deep 
phenotyping of larger libraries, and extend CRISPRi screens for gene function to diverse 
species. 
 
Arrayed CRISPRi approaches to identify gene function 
Chemical-genetic approaches query large numbers of genetic perturbations for their 
ability to influence sensitivity or resistance to small molecule inhibitors of growth (reviewed in 
(Cacace, Kritikos, and Typas 2017)). By profiling growth quantitatively across large numbers of 
chemical conditions, these “phenotypic signatures” have provided an important means to 
identify functional interactions between genes and even to identify functions for uncharacterized 
genes using “guilt by association” logic. In bacteria and in yeast, chemical-genetic screening 
technologies have embraced arrayed library formats, enabling collection of chemical 
phenotypes of bacterial genome-wide deletion libraries (Nichols et al. 2011; Shiver et al. 2016; 
Kritikos et al. 2017) and heterozygous and homozygous yeast deletion libraries (Hillenmeyer et 
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al. 2008). Importantly, the ability to screen yeast genes in a haploid state (heterozygous gene 
deletions) extended the surveyable genetic space to essential genes—genes for which a cell 
cannot tolerate the loss of both copies. The profiling of bacterial essential genes has now 
recently moved into the same theoretical domain, using CRISPRi libraries that partially reduce 
essential genes’ expression. This has enabled the first characterization of a bacterial essential 
gene interaction network in B. subtilis, importantly using phenotypic signatures to link one 
essential gene of unknown function (ylaN) to known pathways in iron-sulfur cluster biogenesis 
(Peters et al. 2016). 
 Chemical-genetic profiling is reliant on the number, diversity, and specificity of conditions 
available in which to screen for phenotypes in order to resolve the functions of cellular 
pathways. Therefore, the use of small molecule antibiotics has been primary. Importantly, there 
is a secondary outcome of comprehensively screening for the determinants of antibiotic 
resistances, which is a more complete picture of the intrinsic and acquirable mechanisms of 
resistance that bacteria possess (Shiver et al. 2016). The ability to screen essential genes for 
their contribution to these mechanisms may be profound, as essential genes are usually the 
direct targets of drugs (Peters et al. 2016) and are largely conserved across diverse species 
(Koo et al. 2017; Grazziotin, Vidal, and Venancio 2015). Datasets of chemical-genetic 
interactions for bacterial essential genes may also support predictions of synergistic antibiotic 
combinations, which have been found to be rare (Brochado et al. 2018). As more species are 
screened and phenotyped in this manner, the generalizability of chemical-genetic interactions—
and therefore antibiotic resistance and sensitization mechanisms—can be assessed. 
 Morphological variation is another source of complex and quantifiable phenotypes with 
which to understand gene function (K. C. Huang 2015; Campos et al. 2018). Multiple points can 
be made to support the value of capturing morphological phenotypes from arrayed CRISPRi 
libraries: first, cell morphology is deeply tied to fitness and takes inputs from diverse cellular 
processes; second, cell to cell variability is a meaningful morphological property; third, the 
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dynamics of morphological change over time are informative; and finally, capturing strain 
phenotypes individually can also support more fine-grained analysis including protein 
localization (Kuwada, Traxler, and Wiggins 2015) and subcellular properties such as nucleoid 
structure (Nonejuie et al. 2013). 
 CRISPRi libraries specifically can aid in these approaches by offering the ability to titrate 
gene knockdown. Whereas strong perturbations might converge on one catastrophic 
morphological outcome, slight perturbations may provide more diverse outcomes related to 
specific gene function. Strong knockdown of essential genes, on the other hand, has also been 
useful in ascribing general gene function (Peters et al. 2016; Veening and Liu 2017). The 
microscopy hardware, automated image capture software, and analysis tools have all made 
great strides towards accommodating the capture of many strain phenotypes in parallel (Ursell 
et al. 2017; Shi, Colavin, Lee, et al. 2017; Campos et al. 2018). 
 The future prospects for high-content phenotype capture for arrayed bacterial CRISPRi 
libraries are exciting. In some cases, it will remain easier to design and create arrayed CRISPRi 
libraries than other forms of libraries used for reverse genetic screens, in particular where 
essential gene phenotypes are important. Some complex phenotypes will be best explored 
using assays of separate strains, in particular those phenotypes for which multiplexing is not 
possible (Fuhrer 2016; Breinig et al. 2015), where cell-to-cell heterogeneity is important to 
quantify, or where cross-complementation between different genetic backgrounds is an issue. 
Because arrayed libraries are intrinsically barcoded by their sgRNA spacers, arrayed libraries 
can be pooled before assaying if barcode counting by next-generation sequencing is available. 
This approach ensures an even distribution of each mutant, which can aid in sensitivity for 
enrichment or depletion assays (Peters et al. 2019). Arrayed libraries might also provide a 
helpful starting position for the investigation of genetic interactions. 
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Genome-wide, pooled CRISPRi libraries to characterize specific phenotypes 
In the second mode of CRISPRi screens for gene function, pooled library construction 
achieves high complexity, allowing comprehensive analysis of many genes with high statistical 
power. This has already been applied to the identification of genes that promote a fundamental 
bacterial property: growth in rich media. While these examples of genome wide tiling CRISPRi 
libraries in E. coli (Wang et al. 2018; Cui et al. 2018) have explored the sources of false 
positives in depletion based screens, their use in an understudied Vibrio species (Lee et al. 
2019) has clearly demonstrated their value in identifying new biology.  
The contributions of genes to growth can themselves be dissected further in these 
pooled assays. For example, titrating knockdown of essential genes using single-mismatch 
sgRNAs has allowed the characterization of “knockdown-fitness curves” representing the 
relationship between attempted knockdown and growth rate (Hawkins et al. 2019). This 
relationship encompasses the ways in which bacteria may be robust to CRISPRi knockdown—
expression of essential genes in excess of what they’re required to support growth, or feedback 
on expression to maintain optimal levels (Rousset et al. 2018)—and can identify points of 
vulnerability, where no robustness to knockdown is observed. These features feed into the 
reconceptualization of essentiality as a quantitative trait with many facets, including evolvability 
and environmental dependence (Rancati et al. 2018). Large, complex libraries also support the 
evaluation of essentiality with respect to genetic and environmental contexts, for example by 
screening a common pool of sgRNAs in differing genetic backgrounds, or by testing depletion in 
different conditions. The use of simple enrichment or depletion screens to identify genes 
contributing to a specific process of interest is already being explored. For example, tolerance to 
the presence of industrial chemicals is a desirable feature for bioproduction (Wang et al. 2018), 
or in an interesting dissection of a more complex phenotype, genes supporting the infection and 
reproduction of diverse phage (Rousset et al. 2018). 
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With regards to large pooled CRISPRi libraries, a few technical points continue to arise 
and have been addressed using distinct methodologies from different groups. First and foremost 
is the quantification of per-strain fitness in optimal growth conditions. Following work in 
mammalian systems with CRISPR/CRISPRi libraries, some recent studies (Hawkins et al. 2019; 
Wang et al. 2018) have favored the use of growth metrics that use steady-state growth 
assumptions to calculate effective doubling time relative to an estimate of wild-type doubling 
time (Gilbert et al. 2014; Kampmann, Bassik, and Weissman 2013; Jost et al. 2019). This 
approach requires accurate estimation of wild-type doubling, which can be done using large 
numbers of unique non-targeting sgRNAs and provides an effective means of distinguishing 
slight growth phenotypes from noise. It also requires, however, that steady-state growth 
assumptions are reasonable given the experimental design, for example by maintaining 
exponential growth through back-dilution. In other cases, the experimental question does not 
rely on differentiating intermediate phenotypes, and rather seeks to categorize genes as (for 
example) growth promoting or not. In these cases, recent work has avoided the use of non-
targeting control sgRNAs and instead estimated significance using the statistical framework 
from common RNA-seq approaches implemented in DESeq2 (Love, Huber, and Anders 2014) 
or using approaches to maximize sensitivity to small effect sizes using maximum likelihood 
estimates and combining the information from multiple sgRNAs targeting the same gene (Lee et 
al. 2019; W. Li et al. 2014).  
In the future, we anticipate the development of further assays for combination with 
CRISPRi libraries in a few specific directions. First, screens for complex phenotypes that 
support follow up screens for each step of the biological process of interest. Second, the use of 
fitness-independent enrichments and depletions. FACS-based separation of complex libraries 
using differences in fluorescence (Hawkins et al. 2019) or even morphological characteristics 
like single-cell width (Shi, Colavin, Bigos, et al. 2017) is a facile method well-suited to genome-
scale questions. Fluorescence can be tied to pathway activation (i.e. signaling, stress response 
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activation, differentiation processes) for a genome scale library. Finally, the growing application 
of CRISPRi tools to diverse bacterial species (Peters et al. 2019) will provide access to more 
complex and relevant phenotypes from non-model species, including pathogenesis (Qu et al. 
2019), but also provide an exciting new lens with which to view gene function. The cross-
species comparison of gene function, in particular for largely conserved sets of genes such as 
the essential genes, using directly comparable CRISPRi tools, will provide an unprecedented 
view of the fundamental requirements of bacterial cell physiology and where adaptation has 
allowed new properties to emerge. 
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Chapter 2 
Functional analysis of E. coli essential genes using CRISPRi   
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INTRODUCTION 
 Bacterial essential genes encode for the fundamental reactions of cellular life and are 
often the direct targets of antibiotics, but the challenges of manipulating them genetically have 
thus far precluded systematic approaches to understanding their roles in vivo. CRISPR 
interference (CRISPRi) for the titratable knockdown of bacterial genes (Qi et al. 2013; Bikard et 
al. 2013; Peters et al. 2016) is positioned to narrow the gap between essential genes and their 
cellular phenotypes, however few systematic phenotypic studies have been completed (Peters 
et al. 2016; Veening and Liu 2017). High-dimensional phenotyping approaches such as 
chemical-genetic screening (Nichols et al. 2011; Shiver et al. 2016) and morphological profiling 
(Veening and Liu 2017; Nonejuie et al. 2013; Peters et al. 2016; Campos et al. 2018) each 
present high-throughput modalities with which to capture large numbers of independent, 
quantitative phenotypes of arrayed bacterial libraries. For example, chemical-genetic screens of 
the Escherichia coli non-essential gene deletion library (Baba et al. 2006) have identified 
functional interactions on the basis of shared chemical signatures (Nichols et al. 2011) as well 
as surveying available cellular mechanisms of antibiotic resistance (Shiver et al. 2016). The 
extension of these screening technologies to the phenotypes of slight essential gene depletions 
has already yielded surprising cross-pathway functional interactions of essential genes and 
further insights into antibiotic action in the model Gram-positive Bacillus subtilis (Peters et al. 
2016). Furthermore, the titratable nature of CRISPRi for perturbing essential gene levels allow 
both the sensitive probing of key regulators of cell morphology, but also exploration of “terminal 
phenotypes” in which essential genes are fully repressed, each reflecting important aspects of 
gene function (Peters et al. 2016).  
 As CRISPRi has been established as a facile tool with which to study essential genes 
diverse microbial species (Lee et al. 2019; Veening and Liu 2017; Rock et al. 2017; Peters et al. 
2019), it presents a unique opportunity to compare the conservation of essential gene functions 
across diverged species (Hawkins et al. 2019). A major distinction in the bacterial domain is the 
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presence of the Gram-negative specific outer membrane across gammaproteobacterial and 
other major pathogens and commensal species. The outer membrane is a complex structure 
that defines a unique bacterial compartment (the periplasm) and provides protection against 
small molecule and other physical stressors (Rojas et al. 2018) in the environment. Despite its 
centrality in bacterial physiology, major gaps in our knowledge of how the barrier function of this 
structure is created, in part due to its essential nature in Gram-negative species. Finally, 
comparisons across species will fruitfully explore differences in the morphological space 
available to different species based on their intrinsic structural differences. 
 Motivated by this potential, here we systematically profile the chemical and 
morphological phenotypes of an E. coli essential gene knockdown library. By strategically 
aligning our assays with previously published datasets from a B. subtilis essential gene 
knockdown library (Peters et al. 2016), we are able to leverage this comparison to identify 
shared and Gram-negative specific mechanisms of intrinsic antibiotic resistance, as well as the 
primary regulators of cell morphology. Finally, we explore a novel phenomenon during sub-
saturating CRISPRi targeting in bacteria which interacts non-productively with native feedback 
regulatory circuits on gene expression. We show that this feedback does not successfully 
restore homeostasis, and that dysregulation can take the form of increased heterogeneity in 
expression levels and other cellular phenotypes. 
 
RESULTS AND DISCUSSION 
Chromosomal CRISPRi enables the systematic functional study of essential genes in E. 
coli 
To systematically analyze the functions of essential genes in the model Gram-negative 
bacterium Escherichia coli, we designed an inducible, chromosomally integrated CRISPRi 
system that is calibrated to achieve 50% knockdown in the absence of inducer (Figure 2.1A). 
Addition of IPTG reduces expression of an rfp target from 50% to ~7% in a uniform and 
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concentration-dependent manner (Figure 2.1B). Our arrayed library of 479 CRISPRi strains 
(Table 2.1), consists of 266 high-confidence essential genes, 81 genes of uncertain essentiality, 
and 132 non-essential or conditionally essential genes (Methods) (Koo et al. 2017; Baba et al. 
2006; Yamamoto et al. 2009; Goodall et al. 2017; Patrick et al. 2007). Each gene is targeted by 
one computationally optimized sgRNA (“GitHub - Traeki/Sgrna_design” n.d.), with most (86-
95%) either stronger than or within one standard deviation of the mean fitness impact of 
reported sgRNAs targeting that gene (Hawkins et al. 2019; Wang et al. 2018; Rousset et al. 
2018) (Fig. 2.4B). The arrayed nature of our library enables many types of assays, including 
chemical-genetic screening and single-cell microscopy. 
We reproducibly measured (Fig. 2.4C, r=0.897-0.974) relative strain fitness (RF = the 
number of doublings relative to that of non-targeted control strains (Methods)) using a pooled 
competition assay with or without induction (Figure 2.1C). Under induced conditions (1mM 
IPTG) few non-essential genes showed reduced fitness (median RF=1.00, Table 2.2), whereas 
most high-confidence essentials had reduced fitness (~75%, RF≤0.9, median RF=0.73), and 
many had fitness defects even without induction. The bottom 10th percentile of fitness defects 
without induction (RF<0.831, n=23) was enriched for ribosomal proteins and translation factors. 
A similar pooled competition experiment of B. subtilis CRISPRi strains (Peters et al. 2016) 
without induction (knockdown ~33-50%; RF<0.73, n=16) also showed enrichment for ribosomal 
proteins and translation factors with both shared and unique sets of translation factors among 
the most sensitized in these species (Fig. 2.4D). Thus, CRISPRi is effective at sensitizing cells 
specifically to essential gene knockdowns. 
 
Chemical profiling of the essential gene knockdown library generates a robust dataset 
sensitive to operon structure for gene-phenotype assignment 
We performed a chemical-genetic screen of the arrayed E. coli essential gene 
knockdown library, along with 91 representative non-essential deletion strains (Nichols et al. 
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2011) using sub-MIC concentrations of ~100 unique small molecule inhibitors, with some at 
multiple concentrations (150 conditions total, Table 2.3). The small molecules selected either 
elicited strong phenotypes from distinct sets of non-essential deletion strains (Nichols et al. 
2011) or lacked known mechanisms of action (see Methods). We used endpoint growth to 
estimate condition-specific growth rates (quantified by S-scores (Collins et al. 2006)), as in our 
previous chemical-genetic screens (B. subtilis essential CRISPRi library (Peters et al. 2016); E. 
coli non-essential deletion library (Nichols et al. 2011)). We observed high correlation between 
knockdown growth measurements for condition replicates (≥4 replicates per condition, median 
Pearson r=0.711, Fig. 2.4E), and between strain replicates (2-4 replicates per strain, median 
Pearson r=0.680, Fig. 2.4F). Importantly, S-scores of the 91 deletion strains were well 
correlated to those in (Nichols et al. 2011) for the 70 overlapping conditions (Pearson r=0.565; 
Fig. 2.4G). Thus, the data from our screen was highly reproducible. 
We defined significant chemical-gene phenotypes (FDR≤5%; (Nichols et al. 2011; Peters 
et al. 2016)), resulting in 1886 high-confidence phenotypes, with 64.5% of strains (309) having 
at least one phenotype (Figure 2.1D). We compared our phenotypic signatures to known 
functional interactions from several databases using ROC (receiver operating characteristic) 
curves to calculate a true positive rate (TPR) when the false positive rate (FPR) was set at 5% 
(Figure 2.1E). Highly correlated phenotypic signatures were better predictors of more specific 
metrics of functional interactions (e.g. members of the same complex, >4 shared GO biological 
process terms) than higher-level metrics (e.g. members of the same pathway, >2 shared GO 
biological process terms). As expected, the predictive power of all metrics increased by 
excluding strains with few significant phenotypes. This pattern also held in a reanalysis of the B. 
subtilis CRISPRi data in (Peters et al. 2016) for comparable metrics, although differences in 
annotation depth in some cases prevented a direct comparison. Therefore, phenotypic 
signatures capture specific functional interactions between essential genes. 
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In bacterial genomes, genes are often organized into co-transcribed operons. CRISPRi 
targeting reduces the transcript level of downstream operon members by blocking RNA 
polymerase transit and of upstream operon members by an unknown mechanism termed 
“reverse polarity” (Peters et al. 2015, 2016). Using a simple bioinformatic definition of operons 
(Methods), we found that phenotypic signatures were predictive of operons in both E. coli and B. 
subtilis, whether operons had consistent functions (>=50% of members sharing one GO 
biological process term) or were of mixed function (Figure 2.1E). However, using ROC analysis 
exclusively on genes from mixed function operons was less predictive of functional interactions 
than using only single genes (genes not predicted to be in an operon), suggesting that targeting 
mixed-function operons causes multiple perturbations that can obscure the phenotypic signature 
of the targeted gene.  
 
Chemical profiling of the essential knockdown library provides a novel lens for cross-
species comparisons of essential pathways 
The direct targets of most antibiotics are conserved across even distantly related 
species. Thus, antibiotics are species-agnostic probes of bacterial cell biology, enabling 
comparison of E. coli and B. subtilis enrichment patterns (data from (Peters et al. 2016)). To 
broadly examine the chemical-genetic interactions, we grouped drugs by their targeted process 
(Figure 2.2A) and looked for patterns of drug sensitization (S-scores<0) that were significantly 
enriched within functional groups of genes (hypergeometric test, Bonferroni corrected p<0.05; 
Figure 2.2B). We observed enriched sensitivities in both species when drug target and gene 
function are directly related: e.g. DNA related stresses and DNA processes (e.g. DNA 
replication), PMF disruptors and quinone biosynthesis and recycling (e.g. riboflavin biosynthesis 
(E. coli) or menaquinone biosynthesis (B. subtilis)), cell wall synthesis inhibitors and cell wall 
biosynthesis genes (e.g. peptidoglycan biosynthesis), tetrahydrofolate inhibitors and genes in 
tetrahydrofolate biosynthesis, and protein synthesis inhibitors and translation factors (e.g. 
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aminoacyl-tRNA metabolism). Intriguingly, one shared enrichment pattern—knockdown of cell 
wall and cell division genes causing sensitivities to DNA damaging stresses—is not readily 
explained by direct synergistic effects. This observation suggests an evolutionarily conserved 
connection between the cell wall and DNA damage. Additionally, we observe differing 
enrichment patterns for some drug categories (e.g. protein synthesis) that are also not 
explained by direct effects. We next investigate these two cases of commonality and difference, 
and specifically how the latter may be attributed to the central distinction between E. coli and B. 
subtilis: the presence of the Gram-negative specific outer membrane (OM).  
 
The knockdowns of essential cell wall and cell division genes independently contribute 
to DNA damage sensitivity 
Knockdowns of cell wall or cell division genes increase sensitivity to DNA damaging 
stresses in both E. coli and B. subtilis, responding to ciprofloxacin in both species (Fig. 2.5A,B). 
As these knockdowns do not induce the SOS response in either species (Fig. 2.5C), they are 
unlikely to impact genome integrity in a way that is sensed by RecA/LexA. Two findings 
suggested that cell wall and cell division knockdowns independently contribute to DNA damage 
sensitization in E. coli. First, cell wall biosynthesis genes (e.g. murB) and cell division genes 
(e.g. minE) not co-transcribed with the other gene class are sensitized (Fig. 2.5A). Second, 
analysis of transcript levels in single knockdown strains of adjacent cell wall and cell division 
genes (Conway et al. 2014; Lalanne et al. 2018) (Figure 2.2C) reveal four transcriptionally 
independent units comprised exclusively or predominantly of either cell wall or cell division 
genes (Figure 2.2D), again suggesting independent effects on the DNA damage phenotype. 
Using a liquid growth assay to monitor growth with or without sub-inhibitory 
concentrations of the chain-terminating nucleoside analogue azidothymidine (Elwell,’ et al. 
1987), we first demonstrated that both cell division (ftsA, ftsL) and cell wall biosynthesis (murE) 
gene knockdowns were sensitized to DNA damage compared to a control strain (Figure 2.2E, 
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Fig. 2.5D). We then asked whether the observed DNA damage sensitivity results from 
enhancing SulA-mediated division inhibition during SOS, where SulA prevents FtsZ 
polymerization during stress, and is then degraded by Lon during recovery (Mukherjee, Cao, 
and Lutkenhaus 1998; Dajkovic, Mukherjee, and Lutkenhaus 2008; Chen, Milam, and Erickson 
2012). Consistent with this hypothesis, deleting sulA from the ftsL and ftsA cell division 
knockdown strains partially alleviated their sensitivity to azidothymidine (Figure 2.2E, Fig. 2.5D). 
Our finding that cell division knockdowns synergize with SulA is also consistent with the finding 
that lon is essential in strains with slight division defects (e.g. reduced-expression ftsZ mutants 
(Nazir and Harinarayanan 2016)) in a sulA-dependent manner, and that preventing SulA 
degradation (∆lon strain) (Nichols et al. 2011) sensitizes cells to azidothymidine.  
Interestingly, deleting sulA had no effect on DNA damage sensitization in the murE 
knockdown strain (Figure 2.2E, Fig. 2.5D). murE is less sensitized to DNA damage than ftsL/A, 
making it unlikely that the lack of effect of ∆sulA simply reflects a more severe division defect of 
murE. Instead, murE is likely to have a distinct mechanism for sensitization. Additionally, partial 
rescue of ftsL and ftsA knockdowns by ∆sulA raises the possibility that additional DNA damage-
induced division inhibitors contribute to their sensitization (Maguin et al. 1986; Jaffe, D’Ari, and 
Norris 1986; Modell, Hopkins, and Laub 2011). In summary, our results are in agreement with 
complex coordination between peptidoglycan biosynthesis, cell division and genome integrity 
and/or replication, mediated in part by SulA and in part by as yet unknown mechanism(s). 
 
Contributions to the barrier function of the outer membrane 
Although the contributions of individual genes to barrier function has been documented  
(Vuorio and Vaara 1992; Galloway and Raetz 1990; Normark 1970; Young and Silver 1991; 
Grundstrom, Normark, and Magnusson 1980; Vaara and Nurminen 1999; Sperandeo et al. 
2008; Sampson, Misra, and Benson 1989; Ruiz et al. 2005; Malinverni et al. 2006; Wu et al. 
2005; Doerrler and Raetz 2005), our dataset is the first systematic interrogation of the 
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contributions of essential and many non-essential genes to the intrinsic resistance mechanisms 
provided by the Gram-negative outer membrane. There is currently great interest in 
reengineering Gram-positive-restricted antibiotics to meet the challenge of growing antibiotic 
resistance in Gram-negative pathogens, and design rules must contend with the unique 
permeability barrier imposed by the Gram-negative outer membrane (Richter and Hergenrother 
2018). To advance the development of such rules, we comprehensively explored the signatures 
of outer membrane permeability in our dataset.  
We first determined whether the processes inhibited by antibiotics or properties of the 
antibiotics themselves (irrespective of targeted process) were responsible for the enriched 
sensitivity of the 17 OM gene depletions to inhibitors of protein synthesis, transcription, and 
membrane stability (Figure 2.1A). Using tSNE to cluster all conditions based on OM gene 
knockdown phenotypes, we found no clustering based on targeted pathway (Figure 2.2F), but 
strong clustering of the 9 antibiotics in our screen unable to accumulate in E. coli (intracellular 
accumulation <300 nmol/1012 CFU (Richter et al. 2017)). We broadened this analysis by 
identifying additional strains specifically sensitized to non-accumulating antibiotics, and 
additional small molecule inhibitors highly correlated with at least one non-accumulating 
antibiotic (Figure 2.2H). We identified 24 additional compounds (33 total) whose phenotypic 
signatures among OM genes are strongly correlated with those of the non-accumulating drugs. 
These compounds were highly correlated as a group (median Pearson r=0.549 within outer 
membrane gene phenotypes; Figure 2.2H), and include molecules acting at the inner 
membrane either by disrupting the proton motive force (phenazine and triclosan (Domenech et 
al. 2019)) or acting as detergents (bile salts, benzalkonium, and chlorpromazine); as well as 
others with cytoplasmic targets, which may be OM-limited based on their large molecular 
weights (clarithromycin, spiramycin, bleomycin, actinomycin D, holomycin/phleomycin, 
ceftazidime, oxacillin) (Table 2.3). 
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Genes specifically sensitized to non-accumulating antibiotics (hypergeometric test, 
p<0.05) were predominantly from the pathways of LPS biosynthesis (lpxABD, DrfaC, DrfaE, 
DlpcA), LPS transport (lptACEG), outer-membrane protein chaperones and insertion 
machineries (bamA, DbamB, DsurA) and non-essential efflux transporters (DacrB, DtolC); each 
group exhibited distinct sensitization patterns. LPS biosynthesis genes were broadly sensitized 
to all 33 inhibitors, as were the major efflux machinery genes (acrB, tolC), except for retaining 
resistance to vancomycin and rifampicin, which may be poor efflux substrates because they 
have the highest molecular weights. The broad sensitization of acrB and tolC may result from 
reduced capacity to specifically efflux antibiotics, and/or from increased general permeability 
caused by membrane stress (Mateus et al. 2018). By contrast, LPS transport machinery genes 
(the Lpt complex) were predominantly sensitized to non-accumulating antibiotics (except lptG). 
These restricted sensitivities represent either distinct cellular outcomes from perturbing 
biosynthesis vs. transport or indicate that LPS biosynthesis is rate-limiting for populating the 
outer leaflet with LPS. Genes involved in the folding or insertion of outer membrane proteins 
(the Bam complex) were sensitized only to larger non-accumulating antibiotics, possibly 
indicating a defect in permeability but not efflux, the reverse of the phenotypic signatures of the 
efflux deletions. These data indicate that the processes of permeability and efflux can be 
decoupled. The sensitivity of LPS biosynthesis knockdown strains to both effluxed and 
(potentially) non-effluxed antibiotics raises the possibility that LPS content both limits 
permeability and is required for efficient efflux.  
We were particularly interested in understanding the genes most strongly sensitized to 
non-accumulating antibiotics, most of which function in LPS biosynthesis. Because CRISPRi 
knockdown affects operons, and some of these genes are adjacent (Figure 2.2I), we determined 
whether each gene independently contributed to sensitization. Comparison of the total 
phenotypic signatures upon knockdown suggested a highly similar phenotypic outcome from 
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targeting bamA, lpxD, fabZ, lpxA, and lpxB, but not from targeting upstream of bamA (uppS, 
cdsA, rseP) (Figure 2.2I). bamA and lpxD had relatively isolated effects on transcription when 
assayed by mRNA-seq (Figure 2.2J), possibly because knockdown induced sE (Fig. 2.5E), 
whose multiple promoters might alleviate CRISPRi knockdown (Figure 2.2J). Expression of non-
targeted variants of bamA or lpxD each restored wild-type levels of vancomycin resistance to 
their respective knockdown strains, suggesting independent contributions to OM integrity 
(Figure 2.2K). In contrast, targeting lpxB affected the expression of many genes (fabZ, lpxA, 
lpxB, rnhB, dnaE and accA) (Figure 2.2J). We discounted dnaE and accA since their 
phenotypes when targeted are inconsistent with an outer membrane integrity role (Figure 2.2I), 
and focused on fabZ and lpxA, the genes most strongly sensitized to vancomycin. Their 
sensitivity upon knockdown was alleviated both by complementation with non-targeted variants 
(Figure 2.2K) and by expression of the other gene (Fig. 2.5F), suggesting that each may 
contribute to vancomycin resistance. On its face this result presents an intriguing paradox, as 
LpxA and FabZ compete for substrates at the branchpoint between Lipid A biosynthesis and 
fatty acid biosynthesis (Figure 2.2L). 
Our screen also identified novel sensitized CRISPRi strains whose targets had not 
previously been connected to barrier function. We discounted candidates reflecting secondary 
effects due to a) operon level knockdown (e.g. leuS and holA are in the lptE operon); b) 
upstream effects on LPS biosynthesis (e.g. glmS); c) imperfect overlap with non-accumulating 
drug set sensitivity (e.g. zipA, parE, rpsK). However, alaS, an alanine-tRNA ligase, did not have 
any of these confounding factors and hence may have a novel role in barrier function. Its 
knockdown phenotypes are strongly correlated with those of outer membrane genes (median 
r=0.476 with OM genes). We verified that knockdown in uninduced conditions (the conditions of 
the screen) affects transcript level, and showed that alaS expression was restored by full 
knockdown (Fig. 2.5G), as expected from the transcriptional feedback of AlaS (Putney and 
Schimmel 1981). This known feedback could explain lack of a phenotype in our vancomycin 
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sensitivity assay (Figure 2.2K), as these experiments are done under partial induction, where 
transcriptional compensation is expected. Importantly, alaS overexpression conferred slight 
resistance to vancomycin (Figure 2.2K), consistent with alaS having a homeostatic or stress-
induced role in maintaining the OM barrier. The mechanism by which this occurs remains to be 
elucidated; aminoacyl-tRNA synthases (ARS) in other Gram-negative species often protect 
against cationic antimicrobial peptides (CAMPs) via Lipid A modifications (Fields and Roy 2018; 
Klein et al. 2009) although there are no known cases in E. coli. 
In summary, we have systematically catalogued the contributions of essential and non-
essential genes to OM integrity, with three important findings. First, our results reveal the 
profound effects of slight knockdown of LPS biosynthesis genes on drug entry, finding that a 2-
fold knockdown of genes in Lipid A biosynthesis was as effective in allowing drug entry as 
deletion of later non-essential modifications of LPS core (rfaA, rfaE, lpcA: classical “deep rough” 
mutants). Our evidence is consistent with FabZ contributing to intrinsic vancomycin resistance 
via maintenance of the OM barrier, however it may also be the case that fabZ knockdown and 
complementation are primarily acting on flux through the LpxA Lipid A biosynthesis branch. We 
explore these possibilities further in the concluding perspective. Second, we find that LPS 
transport is more robust to knockdown than LPS synthesis in terms of increasing OM 
permeability. Finally, the broad and significant effects of alaS knockdown suggest that it may be 
an interesting drug target, as other aminoacyl-tRNA synthases have been (Hurdle, O’Neill, and 
Chopra 2005). 
 
Predicted direct-target interactions reveal native feedback regulation of essential gene 
expression 
Slight depletion of antibiotic targets should sensitize cells to the cognate antibiotic 
inhibitor, as has been observed in some cases in B. subtilis (Peters et al. 2016). Surprisingly, 
only 3/15 of the known antibiotic-target interactions in our screen were significantly sensitized 
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(FDR≤5%), although a majority of the remainder (7/12=58%) exhibited sensitization of “on-
pathway” or related genes (Figure 2.3A). This suggests that these antibiotics and sgRNAs 
generally are active, but that compensatory regulation might obscure synergy. We selected 4 
cases (fabB/cerulenin; rho/bicyclomycin; fusA/fusidic acid; mreB/A22) and one sensitized 
control (fabI/triclosan) for study. Quantifying transcript abundance without and with saturating 
induction, as compared to targeting rfp, revealed that our positive control, fabI/triclosan, and 
fabB/cerulenin, which was not sensitized, exhibited the expected knockdown efficacy (Figure 
2.3B). Lack of a fabB phenotype may be due to the presence of FabF, a FabB homolog that is 
non-essential in E. coli but that is also inhibited by cerulenin (Price et al. 2001). Importantly, B. 
subtilis has only FabF (Koo et al. 2017) and the knockdown of fabF is sensitized to cerulenin 
(Figure 2.3A) (Peters et al. 2016). In contrast, rho, fusA and mreB transcripts were each present 
above wildtype levels when targeted with CRISPRi without induction. In each case, further 
induction of CRISPRi knockdown restored knockdown, suggesting that the cell has a limited 
capacity to compensate for reduced expression of these genes.  
We developed two reporters to quantitatively measure knockdown and feedback at the 
single-cell level. The “knockdown reporter” drives sfgfp expression from an upstream region 
containing the native promoter and the 5’ end of the gene (Zaslaver et al. 2006), and reports on 
expression at the endogenous locus: the net result of knockdown and compensatory regulation. 
The “feedback reporter” is identical to the knockdown reporter, except that its PAM sequence 
has been mutated so that expression reports only upregulation (Figure 2.3C). We explored two 
cases with well characterized negative feedback regulation (rho, fusA), and a third where 
feedback is not completely understood (gyrA). 
Rho prematurely terminates its own expression in its leader sequence (rhoL), allowing 
Rho to directly downregulate its own production (Matsumoto et al. 1986). Our reporter system 
confirms that non-saturating (uninduced conditions) CRISPRi slightly upregulates rho (Rousset 
et al. 2018). We further show that upregulation is uniform at the single-cell level, is overcome by 
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further induction of CRISPRi, and that bicyclomycin, a direct inhibitor of Rho, phenocopies the 
rho knockdown (Figure 2.3D). The bicyclomycin results confirm that both knockdown and 
feedback reporters are responsive to Rho activity levels. As the rho knockdown strain has no 
significant chemical phenotypes in the screen data, this overactive compensation may 
successfully approximate wildtype levels of expression without causing drastic cellular 
dysfunction. 
Negative feedback of the fusA transcription unit is mediated by RpsG, which binds to an 
mRNA site upstream of its ORF and inhibits the translational coupling between rpsL and rpsG-
fusA-tufA (Saito, Mattheakis, and Nomura 1994; Saito and Nomura 1994). A feedback reporter 
containing both the promoter and RpsG binding-site is upregulated in a fusA knockdown strain 
(Figure 2.3E), but mutations that disrupt RpsG binding (Saito and Nomura 1994) abrogate this 
upregulation. Thus, CRISPRi-induced feedback depends solely on RpsG binding, a finding we 
validated by showing that inhibiting FusA (EF-G) activity with fusidic acid does not upregulate 
expression (Figure 2.3E). Importantly, the fusA knockdown has significant chemical phenotypes, 
potentially owing to the dysregulation of multiple key translation factors (fusA/EF-G, tufA/EF-Tu) 
and ribosomal proteins (RpsL, RpsG) which are no longer responsive to (presumably) excess 
RpsG. 
Finally, we probed the complex interactions that maintain genomic supercoiling. DNA 
gyrase (encoded by gyrAB) introduces negative supercoils and its promoter activity increases 
when supercoiling is decreased (Rolf Menzel and Gellert 1983; R. Menzel and Gellert 1987). 
The non-essential topoisomerase 1 (topA) antagonizes gyrase action by relaxing DNA 
supercoils (Gellert et al. 1982). Additionally, topoisomerase IV (parCE) has an essential role in 
decatenating chromosomes following replication (Zechiedrich, Khodursky, and Cozzarelli 1997). 
Novobiocin inhibits the activities of both gyrB and parE in vivo (Hardy and Cozzarelli 2003). 
Knockdown of parE but not gyrB was sensitized to novobiocin in both E. coli and B. subtilis, 
suggesting a compensatory mechanism specific to gyrB that may be shared. 
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Our chromosomally integrated feedback reporter revealed that increasing knockdown of 
either gyrA or gyrB upregulated expression of both gyrA and gyrB promoters (Figure 2.3F), 
likely preventing their knockdown (median feedback reporter expression=0.97 for gyrA and 1.4 
for gyrB relative to non-targeting strain control). Notably, topA is also upregulated in the gyrA 
and gyrB knockdown strains even at basal knockdown, suggesting that compensation at the 
gyrA and gyrB promoters does not precisely restore native supercoiling, triggering 
overexpression of topA (Y. C. Tse-Dinh and Beran 1988; Y.-C. Tse-Dinh 1985). These results 
may suggest that cells oscillate between a hyper- and hypo-supercoiled state as DNA gyrase 
levels fluctuate with slight knockdown. Importantly, while the contributions of supercoiling-
sensitive promoters of gyrA and gyrB in E. coli to homeostatic control of genomic supercoiling 
have been deeply explored, it is unclear whether the same paradigm maintains supercoiling in 
Gram-positives. Some Streptomyces have been shown to transcriptionally regulate gyrA and 
gyrB in response to short-term supercoiling stress (Szafran et al. 2016), while other evidence 
from B. subtilis suggests that mutations that increase Topo IV expression are a more facile way 
to rebalance supercoiling, perhaps indicating additional constraints on DNA gyrase levels (Reuß 
et al. 2019). The lack of sensitization of gyrAB knockdowns in B. subtilis may suggest that, like 
E. coli and Streptomyces, regulatory feedback is equipped to manage minor challenges to 
supercoiling homeostasis.  
Taken together, these data show that feedback regulation actively tries to restore 
homeostasis when essential genes are depleted, and furthermore that even in conditions of 
sub-saturating CRISPRi targeting homeostasis may not be restored. Specifically, these studies 
indicate that sub-saturating targeting of rho leads to uniform upregulation (2-fold); that feedback 
on expression of the fus operon is regulated solely by RpsG with no contribution from fusA (EF-
G); and that targeting of DNA gyrase subunits causes dysregulation of its own expression and 
that of other supercoiling-controlled genes. More broadly, this methodology will permit 
systematic analysis of the input-output relationships of regulatory circuits governing expression 
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at the single-cell level and open the door to systematic discovery and analysis of the regulatory 
mechanisms governing essential gene expression.  
 
PERSPECTIVE 
Here we describe the first systematic exploration of the phenotypes of partial essential 
gene depletion in the model Gram-negative bacterium E. coli, shedding new light on the roles of 
essential gene products in vivo. Using high-throughput quantitative chemical screens, we 
identified strengths and limitations of CRISPRi for the identification of gene phenotypes, namely 
that knockdown phenotypes reflect perturbations to the combined functions of all operon 
members. Nonetheless, we identify an underexplored mechanism of sensitization to DNA 
damage caused by slight knockdown of genes involved in cell wall biosynthesis and cell 
division; a connection that is shared between E. coli and B. subtilis. We identify one mechanism 
of interaction between these two processes which is the action of SOS-induced cell division 
inhibitors, and specifically demonstrate the importance of SulA in mediating sensitivity of cell 
division (partially) but not cell wall biosynthesis gene knockdowns. It is possible that a unifying 
connection can be found between the cell wall and cell division knockdowns that explains the 
remaining sensitivity of cell division and the totality of the cell wall biosynthesis gene 
knockdowns. Alternatively, perturbations to either cell wall synthesis or cell division may each 
connect to DNA damage by their own secondary mechanisms. For example, interfering with cell 
division has been shown in B. subtilis to irreversibly prevent DNA replication initiation (Arjes et 
al. 2014), though such a mechanism in E. coli has not been completely described (Sánchez-
Gorostiaga et al. 2016). Among all general classes of drug targets, cell wall targeting and DNA 
targeting drugs demonstrate synergy when combined in gamma-proteobacteria, a relatively rare 
characteristic of antibiotic combinations (Brochado et al. 2018). 
We pursue an interesting and medically important phenotype of outer membrane 
permeability, identified by its broad-spectrum antibiotic sensitization which was absent in the B. 
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subtilis CRISPRi dataset. We identify other small molecule stresses that synergize with outer 
membrane permeability, identifying compounds that disrupt the inner membrane and the proton 
motive force, suggesting that these two pathways are reliant on the protective barrier of the 
outer membrane for their optimal function. We also identify a large number of antibiotics from 
diverse classes that may be outer membrane limited; further analysis on this set may identify 
and/or clarify rules of compound accumulation in Gram-negative species, an important line of 
research. 
The finding that FabZ may contribute to the OM permeability barrier is a novel one that 
raises intriguing possibilities about the regulation of LPS production. It is possible that the 
primary effect of fabZ targeting is on lpxA expression, suggesting that LpxA levels are a lever 
with which to tune LPS production. LpxA has been neglected as such a point of regulation 
because, although first in the Lipid A biosynthesis pathway, its reaction is thermodynamically 
unfavorable and requires the activity of LpxC downstream as the first committed step; however 
it is known that reduced activity lpxA mutants are sufficient to select for reduced activity fabZ 
mutants (Mohan et al. 1994), consistent with its activity being limiting in extreme cases. LpxC is 
sole known regulator of this branchpoint, and can become stabilized by FabZ overexpression or 
hyperactivity (Zeng et al. 2013; Ogura et al. 1999). Therefore, fabZ overexpression may restore 
the resistant phenotype to the fabZ or lpxA knockdowns by stabilizing LpxC and restoring flux 
towards LPS production. FabZ is the primary dehydratase of unsaturated fatty acid 
biosynthesis, and a model has been proposed in which LpxC stability is favored by increased 
acyl-ACP pools, the result of FabZ activity (Ogura et al. 1999). It is possible that compensation 
via LpxC is only equipped to rebalance flux towards LPS biosynthesis when FabZ activity is 
high, and cannot respond when FabZ activity is too low, or when LPS biosynthesis is depressed 
in the absence of FabZ activity. The synteny of these two genes—fabZ and lpxA—further 
suggests that other regulatory mechanisms are possible. 
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Finally, using a small set of predicted chemical-genetic interactions between antibiotics 
and their direct targets, we find that sub-saturating CRISPRi targeting of some essential genes 
does not cause the predicted sensitization because of regulatory compensation on the targeted 
gene itself. This regulatory compensation follows known features of feedback regulation, and 
some presented evidence suggests that during sub-saturating CRISPRi targeting, cells 
experience fluctuations in the concentration of essential gene products. In other cases, essential 
genes are readily knocked down by CRISPRi, suggesting that cells have flexible requirements 
for some essential gene products and strictly regulate others. The methodology we present here 
for identifying and characterizing feedback regulation caused by CRISPRi perturbation will be 
productively applied to broader screens for this behavior, not limited to essential genes. 
 
MATERIALS AND METHODS 
Experimental model and subject details: 
Microbes 
Escherichia coli strains were cultured in LB medium at 37C, or in MOPS complete with glucose 
(MOPS EZ Rich Defined, Teknova #M2105) at 37C, as indicated. 
 
Method details: 
General strain manipulations and procedures 
CRISPRi strain construction: 
The lambda-att integrating plasmid pCAH63 (Haldimann and Wanner 2001) was modified to 
contain an sgRNA expression cassette to generate pCs-550r in the following steps: the sgRNA 
constant region was cloned from pgRNA-bacteria (Addgene #44251 (Qi et al. 2013)), the 
terminators L3S3P22 and L3S2P21 were cloned up and downstream, respectively, to flank the 
sgRNA cassette, and the sgRNA promoter was changed from BBa_J23119 to PlLac-O1 (Lutz 
and Bujard 1997). New 20nt spacers were cloned into pCs-550r by inverse PCR (Larson et al. 
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2013), Sanger sequenced, and transformed into E. coli BW25113 harboring pINT-ts to promote 
integration at lambda att (Haldimann and Wanner 2001) using CaCl2-competence and selecting 
for chloramphenicol resistance. 
High-efficiency conjugation was used to transfer dcas9 from the chromosome of a donor 
strain to the chromosome of a sgRNA-encoding recipient strain. A “pseudo-Hfr” strain isogenic 
to BW25113 carries the transfer region from F and a spectinomycin marker integrated 
downstream of rhaM (4086kb) (Typas et al. 2008). The dcas9 donor strain was constructed by 
integrating dcas9 and a gentamicin resistance marker at the Tn7 att site (Choi and Schweizer 
2006), adjacent to the origin of transfer, using the Mobile-CRISPRi triparental mating strategy 
(Peters et al. 2019). To clone the Tn7 cassette plasmid, dcas9 was amplified from pdCas9-
bacteria (Addgene #44249) under control of the synthetic promoter BBa_J23105 
(http://parts.igem.org/). Conjugation was performed on LB plates by mixing the dcas9 donor and 
sgRNA recipient in equal ratios, incubating for 5hr at 37C, pinning onto double-selection plates 
(chloramphenicol + gentamicin), and growth overnight. Single colonies from each conjugation 
mix were isolated by streaking onto double-selection plates. 
RFP and RFP-GFP reporter strains for knockdown quantification: 
The rfp cassette including kan marker was PCR amplified from the entry vector used to 
construct the previously described RFP reporter strain (plasmid: pSLQ1232, strain: MG1655 
nfsA::PlLac-O1-mrfp) (Qi et al. 2013), the rfp promoter changed from PLlac-O1 to a minimal 
synthetic promoter (BBa_J23119) {http://parts.igem.org/} to create pSLQ1232-P541-rfp, and 
integrated into BW25113 at nfsA by lambda red recombineering (Thomason et al. 2014) and 
selecting for kanamycin resistance. To construct the rfp-gfp synthetic operon reporter strain, gfp 
was cloned downstream of rfp in pSLQ1232-P541-rfp to create pSLQ1232-P541-rfp-gfp, and 
inserted into the chromosome at nfsA as described above. sgRNA plasmids targeting either rfp 
or gfp (pCs-550r or pCs-550-601, respectively) were integrated into the chromosome in the 
manner described for library plasmids above. Promoter variants were cloned along with dcas9 
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into the Tn7 cassette plasmid, and triparental mating was used to introduce dcas9 cassette into 
the chromosome at Tn7att (as described above). 
Transcriptional reporter plasmids: 
We used transcriptional reporter plasmids selected from, or designed to mimic, the existing 
library from (Zaslaver et al. 2006). If the desired reporter was not a member of the library, the 
upstream region (150-400bp upstream of ORF and 50-100bp within ORF and containing the 
targeted protospacer) was amplified by PCR (see primers in Table 2.1) from the BW25113 
genomic DNA with 25bp flanking sequence and assembled by HiFi (New England Biolabs 
#E2621L) with the PCR-amplified pUA66 vector. In the case of feedback reporters, PAM 
mutations were introduced by quick-change mutagenesis (see primers in Table 2.1). Plasmids 
were transformed into CRISPRi strains by electroporation, selecting for kanamycin resistance. 
Complementation plasmids: 
The ORFs of genes of interest were amplified from E. coli BW25113 genomic DNA (see primers 
in Table 2.1) and assembled into pBAD24 (Guzman et al. 1995) using Gibson assembly (NEB 
HiFi #E2621X). Plasmids were transformed into CRISPRi strains by electroporation, selecting 
for ampicillin resistance. 
ΔsulA CRISPRi strains: 
The sulA::kan allele was first moved into sgRNA recipient strains by P1 transduction 
(Thomason, Costantino, and Court 2007) and selecting for kanamycin resistance. Conjugation 
was used to move dcas9 into the sgRNA ΔsulA recipients, as described above, double-selecting 
for kanamycin- and gentamicin-resistant colonies twice in succession, after which 
chloramphenicol resistance was confirmed by patching. 
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CRISPRi library design, construction, pooled growth experiment 
Design: 
sgRNAs were designed to target genes in Escherichia coli BW25113 having some evidence of 
essentiality in published datasets, as described in the main text and summarized in (see library 
description in Table 2.1). sgRNAs were designed to target within each gene’s ORF near the 5’ 
end, binding the non-template strand, and sgRNAs with multiple potential binding sites were 
avoided, as previously described (Peters et al. 2016). sgRNA design scripts are publicly 
available (“GitHub - Traeki/Sgrna_design” n.d.). 
Arrayed library construction: 
sgRNA plasmids were cloned, verified, and integrated into E. coli BW25113 as described for 
individual strains above. One isolate of each sgRNA recipient was stored by inoculating into 
250ul LB with chloramphenicol in 96 deep-well plates, grown for 6.5hrs, mixed with glycerol, and 
stored at -80C. 
Arrayed sgRNA recipient libraries and arrayed dcas9 donor strain were pinned from glycerol 
stocks to separate LB agar plates using a ROTOR robot (Singer Instruments) and grown 
overnight. The arrayed recipient library was then mixed with the arrayed donor strain by pinning 
onto a new LB agar plate, and then grown for 8 hours to allow conjugation. Patches were mixed 
and transferred to a double-selection agar plate (gentamicin and chloramphenicol) using the 
ROTOR robot and grown overnight. Patches were each individually struck out on double 
selection plates for single colony isolation. To store the CRISPRi library, 2 isolates of each 
strain were inoculated in 250ul LB with chloramphenicol and gentamicin, supplemented with 
0.2% glucose, in 96 deep-well plates, grown for 6.5hrs, mixed with glycerol, and stored at -80C 
in 96 well plates. 
Pooled library construction: 
To enable the use of deep sequencing to quantify relative fitness (see below), an additional ~50 
non-targeting sgRNA plasmids were cloned and integrated into BW25113, as described above. 
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Control sgRNA spacers were selected as a random subset from previously characterized 
control sgRNAs (Hawkins et al. 2019). Construction of the pooled library (all library sgRNAs plus 
control sgRNAs) was identical to that of the arrayed library except that after the second double 
selection of the arrayed library, all patches were scraped from the agar plate, thoroughly mixed, 
and stored as glycerol stocks at -80C. 
Pooled growth experiment: 
To quantify the relative fitness of each CRISPRi strain, we enumerated the relative proportion of 
each sgRNA spacer in the mixed population by deep sequencing, before and after 15 doublings 
in saturating IPTG. Briefly, a single glycerol stock of the pooled library was fully thawed, 
inoculated into 10ml LB at 0.01 OD600, and grown for 2.5hr (final ~0.3 OD600). This culture 
was collected (10ml, t0) and used to inoculate replicate 4ml LB cultures (+/- 1mM IPTG) at 0.01 
OD600, which were then repeatedly grown 130min to 0.3 OD600 (5x doublings) and back-
diluted to 0.01 a total of 3 times (15x doublings). At the endpoint cultures were collected (4ml, 
t15) by pelleting (9000xg 2min) and stored at -80C. The following day genomic DNA was 
extracted using the DNeasy Blood & Tissue kit (Qiagen #69506) with the recommended Gram-
negative pre-treatment and RNAse A treatment. sgRNA spacer sequences were amplified from 
gDNA using Q5 polymerase (New England Biolabs #M0493S) for 14x cycles using custom 
primers containing TruSeq adapters and indices, followed by gel-purification from 8% TBE gels. 
 Spacer sequences were extracted from FASTQ files, counted by exact matching to 
expected library spacers, and their counts normalized within each sample to control for read 
depth. We calculate the fitness as Relative Fitness (Hawkins et al. 2019), where the log2 fold 
change is normalized by the median log2 fold change of the control sgRNAs, and adjusted by 
the number of doublings. All RF values are reported in Table 2.2. 
 The RF values of B. subtilis CRISPRi strains were recalculated from a previous dataset 
(Hawkins et al. 2019), using the same set of control sgRNAs as was used for the E. coli 
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CRISPRi pooled growth experiment. The measurements reflect the activities of the same 
sgRNAs used in the B. subtilis chemical genetic screen and original library (Peters et al. 2016). 
 
Chemical screen of the arrayed CRISPRi library 
Screen procedure 
Chemical screening was performed and chemical-gene scores were calculated as previously 
described (Nichols et al. 2011; Peters et al. 2016; Shiver et al. 2016). Briefly, before screening, 
glycerol stock plates were thawed and robotically pinned onto LB agar plates in 1536 format 
using a ROTOR robot (Singer Instruments) to make the “source” plates. Following overnight 
growth, strains were transferred from source plates to plates containing sub-MIC chemical 
inhibitors/stresses using the ROTOR robot, and grown for 8-18hrs at 37C until the plate as a 
whole had measurable-sized patches, stored at 4C overnight, and imaged the following day 
using the spImager-M plate imaging system (S&P Robotics). 
The strain array contains 2-4 total biological replicates of each CRISPRi strain, and a 
total of 91 deletion strains from the Keio collection (Baba et al. 2006) screened without 
replicates, in randomized positions within the array. Chemical concentrations were determined 
empirically by streaking the background strain (BW25113) on plates with 2-fold concentration 
ranges below the MIC. Concentrations were chosen such that growth was inhibited roughly 50% 
or less, and roughly 50% of small molecules were screened at multiple concentrations. The 
screen contained 4-5 replicates plates of each concentration. Chemical plates for screening 
were poured manually, dried 2 days at room temperature, and inspected for defects before 
screening. All conditions are described in Table 2.3. 
Calculation of condition-specific phenotypes 
Colony sizes were extracted from plate images using the Iris software package (Kritikos et al. 
2017). Spatial effects were normalized using a quadratic function, median and variance of 
colony opacities were normalized between plates, and S-scores were computed using 
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previously described scripts in MATLAB (Collins et al. 2006; Shiver et al. 2016). False discovery 
rates for each condition-specific phenotype were computed from S-scores, on a condition-
specific basis, as previously described (Nichols et al. 2011).  
Further analyses of phenotypes 
Gene-gene correlation validation 
Genes were correlated (Pearson r) based on their phenotypic signatures, and the absolute 
value of gene-gene correlations (|r|) was compared to databases of functional connections in 
ROC analyses using the metrics package in sklearn. A simple definition of operons was used 
and applied to both E. coli and B. subtilis CRISPRi targets: co-directional genes where the ORF 
start is within 50bp of the upstream ORF stop were considered to be in the same operon. For 
comparison to the STRING database of functional interactions, several criteria were used to 
remove lower quality predictions: interactions were considered high quality only if their 
“experimental evidence” score was greater than 699. 
 
Flow cytometry to quantify knockdown and reporter activities 
Growth and flow cytometry analysis of the RFP reporter strains was done as described in 
(Rauch et al. 2017) with minor modifications. Strains were initially inoculated from single 
colonies and grown for ~5hr before dilution instead of overnight. Data was collected on a LSRII 
flow cytometer (BD Biosciences) using the yellow/green laser (561 nm) and the PE-Texas Red® 
detector (610/20 nm). Data for at least 20,000 cells were collected, and median fluorescence 
values were extracted using FlowJo (FlowJo, LLC). Error bars represent the standard deviation 
from 3 or more biological replicates. Data from representative samples were plotted as 
histograms using FlowJo. 
For analysis of the transcriptional reporters, cultures were maintained in kanamycin 
selection throughout, and back-diluted in the presence of IPTG and/or drug treatment for 2-3hr, 
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before data was collected on the same instrument using the blue laser (488 nm) and the FITC 
detector (530/30 nm).  
 
RT-qPCR to quantify knockdown 
Growth and RT-qPCR 
E. coli CRISPRi strains were grown in triplicate from single colonies in pre-warmed 4ml LB for 
2.5hrs before back-dilution (1:80) in pre-warmed 4ml LB +/- 1mM IPTG and growth for 3hr prior 
to collection (OD600 ~ 0.2). The control strains express rfp with or without an sgRNAs targeting 
rfp (“non-targeting”) and were treated identically. Samples were collected (300ul) in 900ul 
TRIzol-LS (Thermo Fisher #10296010) and stored at -20C overnight. The following day RNA 
was extracted according to the TRIzol protocol. RNA was quantified using a NanoDrop 2000c 
Spectrophotometer (Thermo Scientific) to normalize input (500ng input / 20ul reaction). For 
each RT-qPCR probe set and each sample replicate, reactions were performed in triplicate. 
All RT-qPCR assays were done using the Luna Universal One-Step RT-qPCR kit (New 
England Biolabs #E3005S) according to its RT and cycling protocols, in 96 well PCR plates 
(Neptune #3732.X) and measured on a CFX Connect Real-Time System (Bio-Rad). 
RT-qPCR analysis 
Standard curves for each primer pair were first assessed on serially diluted RNA (extracted from 
the CRISPRi control strain) to confirm single melting peaks, strong correlations of technical 
replicates, and to calculate their efficiencies (in accordance with (Sinton, Finlay, and Lynch 
1999)). The relative expression (or Normalized Relative Quantity (NRQ)) of each gene of 
interest in each experimental sample was calculated according to (Hellemans et al. 2008), 
which uses the geometric mean of two reference genes (here: atpB and recA) to normalize the 
probe of interest within each sample, and further calculates the fold-change in relative 
expression compared to a wildtype strain. The “non-targeting” rfp+ strain was considered the 
wildtype for the normalization of all other strains. 
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RNA-seq and 5’-end mapping 
Cultures were grown and RNA extracted as described for RT-qPCR above. 
RNA-seq library prep 
1 ug of purified RNA was fragmented at 95°C for 7 minutes in 1x T4 RNA Ligase buffer (NEB) 
with an equal volume of 2X alkaline fragmentation buffer (0.6 volumes of 100 mM Na2CO3 plus 
4.4 volumes of 100 mM NaHCO3. After 3’end healing with PNK (NEB) in T4 RNA ligase buffer 
for one hour, 3’ ligation to a pre-adenylated, barcoded TruSeq R1 adapter with 5 random bases 
at its 5’ end was performed overnight. The barcoded samples were then pooled and run onto a 
6% TBE-Urea gel for size selection (>15nt insert size), eluted and ethanol precipitated before 
performing ribosomal RNA subtraction (RiboZero). Reverse transcription with SuperScript IV 
(Invitrogen) was performed using a TruSeq R1 RT primer, and followed by ligation of the 
TruSeq R2 adapter to the 3’end of the cDNA overnight, prior to another gel size selection as 
described above. A final PCR of the library was performed with indexed TruSeq PCR primers to 
add the index and P5/P7 flowcell adapters, followed by gel extraction, precipitation and a 
BioAnalyzer (Agilent) run for quality control before sequencing on a HiSeq4000 platform. 
 
RPKM calculations 
The indexed raw sequencing data was demultiplexed according to their R1 barcodes and the 
degenerate linker sequence was clipped using a custom script. Mapping of individual reads to 
the genome of E. coli (GenBank ID U00096.3) was performed with STAR (STAR: ultrafast 
universal RNA-seq aligner, (Dobin et al. 2013)), followed by read counting and calculation of 
RPKM for individual genome regions according to gene annotations from assembly ASM584v2. 
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Complementation of CRISPRi strains and quantification of chemical phenotype 
CRISPRi strains were constructed that were complemented with either gfp or an essential gene 
of interest under control of an arabinose-inducible promoter in pBAD24 (Guzman et al. 1995). 
For each complementing essential gene, the toxicity of over-expression was first assessed by 
growing in 10-fold dilutions of arabinose from 0.2% to 0.0002% and monitoring OD600, and the 
maximum tolerated (without causing growth inhibition) concentration was used in subsequent 
experiments. For strains in which the CRISPRi-targeted gene was complemented, the 
complementation allele was mutated to preserve protein sequence but disrupt CRISPRi 
recognition by mutating either the PAM sequence or 2nt in the seed region (first 7nt adjacent to 
PAM). These mutations were made using quick-change mutagenesis. 
CRISPRi stains complemented with either an essential gene or with gfp were grown in 
competition with an RFP-expressing strain (nfsA::rfp-kan) complemented with gfp. Competitions 
were done in the presence of ampicillin (to maintain the complementation plasmid), 0.01mM 
IPTG to induce CRISPRi knockdown, the previously determined maximum tolerated arabinose 
concentration (0.0002% or 0.2% arabinose), and with or without sub-inhibitory concentrations of 
vancomycin (40ug/ml). 
Strains were first grown to mid-log phase in the presence of ampicillin and arabinose, 
and then diluted to 0.00025 OD with the competitor strain in the specified competition 
conditions, in 300ul in deep 96 well plates, and grown for a total of 4.5hrs (37C, 900RPM). Each 
competition well was then diluted and plates for CFU selecting for gentamicin resistance. 2-3 
competition replicates were used for each experimental strain.  
 
Growth curves to validate azidothymidine sensitivity 
CRISPRi strains and those combined with the sulA deletion were grown in 4ml LB from 
single colonies, and diluted back to OD600=0.005 in 150ul LB with or without 0.025ng/ml 
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azidothymidine. The volumes were grown in microplates (Corning #3631) for 10hr in a Biotek 
Synergy H4 Microplate reader at 37C with fast shaking and measuring OD600 every 6min. 
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FIGURES 
 
 
Figure 2.1. Chromosomal CRISPRi in E. coli enables the knockdown of essential genes 
and chemical phenotyping. (A) Diagram of E. coli chromosomal integration sites for dcas9 
from Streptococcus pyogenes and the chimeric sgRNA and their respective promoters. (B) 
Distribution of single-cell RFP fluorescence values for a chromosomal CRISPRi system as in (A) 
targeting chromosomal rfp and grown with titrating IPTG, compared to cells with no RFP (black 
line, left) and cells with no sgRNA (black line, right). Lower panel depicts the median single-cell 
RFP values as a percent of no-sgRNA control, compared to the concentration of IPTG. (C) 
Relative fitness of each CRISPRi strain grown in a pooled experiment, grown with or without 
1mM IPTG for 15 generations. Strains are separated into categories based on the essentiality of 
their target gene: essential, non-essential, or essentiality uncertain. Right panel depicts the 
uninduced (“No IPTG”) data for targeting essential genes in E. coli compared to the data from 
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(Hawkins et al. 2019) in which essential B. subtilis genes are targeted by slight knockdown (as 
in (Peters et al. 2016)) without induction. (D) Distribution of significant phenotypes (sensitive 
and resistant, FDR<0.05) from the chemical screen for the ~150 conditions tested. CRISPRi 
strains are separated into categories as in (C). Lower panel shows the sums of significant 
phenotypes for each CRISPRi strain, and right panel shows the sums of significant phenotypes 
for each condition. (E) True positive rates (TPR) at FPR=0.05 for all ROC analyses using the 
absolute value of correlation (|Pearson r|) between strains’ phenotypic signatures and evaluated 
on the datasets of functional interaction described at the top. CRISPRi strains without at least 
one significant phenotype were excluded. Top panel shows the results for the chemical screen 
of the E. coli CRISPRi library. Bottom panel shows the results for the chemical screen of the B. 
subtilis CRISPRi library (Peters et al. 2016). 
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Figure 2.2. Cross-species comparison of sensitivity patterns reveals shared and Gram-
negative-specific signatures. (A) Enrichment p-value (hypergeometric test, Bonferroni 
corrected) of GO biological process terms for which E. coli CRISPRi strains targeting genes 
annotated with that term had an enrichment of significant sensitivity phenotypes, for each group 
of stresses as categorized on the y-axis. X-axis shows the p-value of each enrichment. Each 
significantly enriched GO term is colored by a general functional categorization. (B) Enrichments 
as in (A) for significant sensitivity phenotypes in B. subtilis CRISPRi strains. (C) Correlation 
(Pearson r) between chemical phenotype signatures of genes in close genomic proximity with 
functions related to cell wall biosynthesis and cell division. (D) Change in expression (Log2FC) 
for genes of interest caused by CRISPRi targeting of genes selected from the cluster in (C). 
Independently repressible units are demarcated by purple lines. (E) Growth in the presence of 
sub-MIC azidothymidine of E. coli CRISPRi strains and their DsulA variants. Growth is 
measured by the median OD600 measurement following 6-7hrs of growth and averaged across 
two biological replicates. (F) t-SNE clustering of all conditions using the phenotypes of E. coli 
CRISPRi strains targeting genes with OM-related functions. Specific categories of conditions 
are colored as indicated. (G) t-SNE clustering as in (F) with conditions colored by their 
intracellular concentration as measured in (Richter et al. 2017). (H) Expanded analysis of outer 
membrane permeable mutants and their phenotypes. Heatmap showing S-scores of strains 
sensitized to non-accumulating antibiotics. Genes with OM-related functions are indicated with 
asterisks and are as used in (F-G). Non-accumulating antibiotics (<300nmol/1012 CFU) are 
indicated with asterisks. Additional genes are those with significantly enriched sensitivities to 
non-accumulating antibiotics (hypergeometric test, p<0.05). Additional conditions are those that 
were highly correlated with at least one non-accumulating antibiotic condition. (I) Correlation 
(Pearson r) between chemical phenotype signatures of genes in close genomic proximity with 
functions related to outer membrane biogenesis. (J) Change in expression (Log2FC) for genes 
of interest caused by CRISPRi targeting of genes selected from the cluster in (I). Independently 
repressible units are demarcated by purple lines, and annotated sE promoters are indicated in 
blue. (K) Relative growth in sub-MIC vancomycin of E. coli CRISPRi strains and their 
complemented variants, in competition against wildtype. Relative growth is assessed by CFU/ml 
and reflects the fraction of growth in vancomycin compared to untreated, relative to a wildtype 
control. (L) Schematic of the metabolic branch point between fatty acid biosynthesis and Lipid A 
biosynthesis, governed by the activities of FabZ and LpxA/LpxC, respectively. 
 
  
 55 
 
 56 
Figure 2.3. Predicted direct target interactions reveal pervasive feedback controlling 
essential gene expression and triggered by CRISPRi targeting. (A) Predicted direct target 
interactions in the E. coli and B. subtilis CRISPRi chemical genetic screens. All direct target 
pairs are listed and are shown in blue if the direct target knockdown was significantly sensitized 
(FDR<0.05) and in red if not. n.t. not tested. (B) Transcript levels of CRISPRi targeted genes 
measured by RT-qPCR. Wildtype levels of expression, uninduced CRISPRi levels (no IPTG) 
and maximally induced (1mM IPTG) are shown for each targeted gene. Transcript levels are 
shows as Normalized Relative Quantities (NRQ) and the distribution of 2-3 biological replicates 
are shown as boxplots. (C) Schematic of the dual-reporter system to quantify CRISPRi 
knockdown and feedback at the single-cell level. (D) Schematic describing negative 
autoregulation of rho and the knockdown/feedback reporter experiments. Lower panel shows 
the relative median single-cell GFP fluorescence for the strains and reporters as indicated. 
Induction of CRISPRi by IPTG or induction of feedback by drug treatment are each shown along 
the lower x-axis. Lower right panels show the distribution of single-cell GFP values for the rho 
knockdown and feedback reporters. (E) as in (D) for evaluation of fusA feedback regulation. (F) 
as in (D-E) for evaluation of gyrA and gyrB feedback regulation. All reporters in (F) are 
chromosomally integrated at xylA. 
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Figure 2.4. Construction and characterization of the E. coli essential gene CRISPRi 
library. (A) Workflow of the construction of the E. coli CRISPRi library. New spacers are cloned 
in parallel into the plasmid pCs-550r by iPCR, followed by ligation. These plasmids are 
competent to express the full length sgRNA under control of the IPTG-inducible promoter PlLac-
O1. In parallel, each plasmid is integrated into the latt site in the chromosome of a recipient 
wildtype (BW25113) cell using the helper plasmid pINT-ts, and selecting for chloramphenicol 
resistance. These strains are then arrayed in 96-well plates, and comprise the “sgRNA library”. 
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The right branch of the workflow describes the construction of a dcas9 donor strain which is 
competent to transfer dcas9 in single copy to a recipient cell using conjugation. dcas9 was 
cloned into the plasmid pTn7C59 inside a cassette recognized by the site-specific transposase 
Tn7. The plasmid pTn7C59 and the plasmid pTn7C1 (expressing Tn7) are each transferred to a 
recipient pseudo-Hfr strain (Typas et al. 2008) in a tri-parental mating strategy (Peters et al. 
2019), resulting in integration of the dcas9 cassette at the Tn7att in the recipient chromosome. 
The Tn7att site is adjacent to the origin of transfer (OriT) in the dcas9 donor strain, allowing it to 
transfer the dcas9 cassette but not the conjugative machinery (tra region) to a recipient cell. 
Below outlines the mating protocol, the mating and first selection steps of which take place on 
high-density array agar pads, and the final selection step using single colony isolation. (B) The 
relative fitness (RF) of sgRNAs chosen for the E. coli CRISPRi library and their activities 
compared to other sgRNAs targeting the same essential gene in three large-scale screens 
(Wang et al. 2018; Rousset et al. 2018; Hawkins et al. 2019). All fitness values are shown as 
relative fitness, with the mean fitness among all sgRNAs targeting the same gene shown as 
point in the line representing the full distribution. Right of the plots details the percentage of 
sgRNAs selected for this library whose RF values fall within or below 1 standard deviation of the 
mean RF for all sgRNAs targeting that gene. (C) Relative fitness measurements are 
reproducible. Relative fitness is shown for two biological replicates in uninduced “No inducer” 
and induced “1mM IPTG” conditions. Points are colored according to their essentiality 
designation as in Fig. 2.1C. (D) Relative fitness of high-confidence essential homologs in 
uninduced conditions in E. coli and B. subtilis. Essential homologs falling in the bottom 10th 
percentile of essential homologs in either species are labeled. (E) Reproducibility of the 
chemical-genetic screen in E. coli. The distribution of correlations among all condition replicate 
pairs (≥4 replicates per condition, 151 conditions); median Pearson r=0.711. (F) The distribution 
of correlations among all strain replicate pairs (2-4 replicates per strain, 479 strains); median 
Pearson r=0.680. (G) The distribution of correlations for the deletion strains screened among all 
matched conditions with (Nichols et al. 2011) (91 strains, 70 overlapping conditions); Pearson 
r=0.565. 
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Figure 2.5. Shared and Gram-negative specific sensitivity patterns from the chemical-
genetic screens. (A) S-scores of all cell division and cell wall biosynthesis gene knockdowns 
(upper) and DNA replication genes (lower) in E. coli for conditions causing DNA damage. Upper 
shows strains and conditions clustered hierarchically using Euclidean distance. Lower shows 
conditions in the same order as above, and strains clustered. (B) as in (A) for S-scores of B. 
subtilis strains in which cell division or cell wall biosynthesis genes (upper) or DNA replication 
genes (lower) are targeted. Data as in (Peters et al. 2016). (C) RNA-seq of outer membrane, 
cell division, and cell wall biosynthesis genes demonstrates no strong activation of SOS 
response. Log2 fold change (Log2FC) in expression compared to a CRISPRi control strain is 
shown for SOS-induced genes. (D) Growth curves in the presence (blue outline) or absence (no 
outline) of sub-inhibitory azidothymidine. Each panel shows one CRISPRi target, alone or in 
combination with a sulA deletion (∆sulA). Greyed section highlights the timepoints used to 
estimate end-point growth in Fig. 2.2E. (E) as in (C) for genes regulated by sE and Rcs 
pathways. (F) Complementation of vancomycin sensitivity as in Fig. 2.2K. (G) RT-qPCR 
quantification of target transcript levels in an rfp targeting and alaS targeting strain. 
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TABLES 
Table 2.1. Strains and primers used in this study (including CRISPRi libraries). Supplemental 
file. 
Table 2.2. Growth phenotypes from pooled screen. Supplemental file. 
Table 2.3. Chemical screen details and phenotypes. Supplemental file. 
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Mismatch-CRISPRi reveals conserved expression-fitness relationships in bacteria 
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INTRODUCTION 
Bacteria must optimize protein production to maximize survival and growth in constantly 
changing environments. Given the high energetic cost of protein synthesis, optimizing 
expression is particularly important for essential genes: although only ~5-10% of the genome, 
they constitute a disproportionate fraction (~50%) of the proteome (Lalanne et al., 2018) and 
insufficient expression is, by definition, fatal. Previous work using CRISPR interference 
(CRISPRi), hypomorphs, and promoter replacement revealed gene-, environment-, and 
antibiotic-specific fitness effects of altering essential gene expression (Bauer et al., 2015; Dekel 
and Alon, 2005; Eames and Kortemme, 2012; Johnson et al., 2019; Keren et al., 2016; Nichols 
et al., 2011), but the lack of a facile method for systematically perturbing bacterial gene 
expression has thus far prevented a comprehensive understanding of how bacteria optimize 
expression of their essential protein complement. CRISPRi, which represses bacterial 
transcription by targeting a catalytically dead Cas9 (dCas9) to an open reading frame using a 
complementary sgRNA, is an inducible and inherently barcoded system that has been used to 
perturb essential gene expression in its native context. However, tuning transcriptional 
repression by adjusting dCas9 or sgRNA abundance (Liu et al., 2017; Peters et al., 2016) is 
noisy and precludes the interrogation of multiple knockdown levels in a single experiment 
(Vigouroux et al., 2018).  
Here we establish a species-independent approach for predictably titrating CRISPRi 
activity in bacteria using single mismatches in the base-pairing region of sgRNAs. Mismatched 
sgRNAs enable massively parallel interrogation of the fitness effects of many intermediate 
levels of CRISPRi efficacy across genes in a single pooled growth experiment. Building on 
previous studies of off-target and mismatched sgRNA activity (Gilbert et al., 2014; Jost et al., 
2020; Vigouroux et al., 2018), we screened a comprehensive library of mismatched gfp-
targeting sgRNAs in Escherichia coli and Bacillus subtilis and used the data to build a species-
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independent model of mismatched sgRNA activity for bacterial CRISPRi. We used this model to 
explore the expression-fitness landscapes of all essential genes in E. coli and B. subtilis by 
comparing the fitness effects of ~90 mismatched sgRNAs to the predicted levels of CRISPRi 
activity for each essential gene in each species. Our analysis of per gene expression-fitness 
relationships revealed that CRISPRi targeting of different essential genes has different effects 
on cellular fitness, but that these effects are largely conserved within pathways, and between E. 
coli and B. subtilis homologs. The conservation of expression-fitness relationships for most 
genes over >2 billion years suggests that conserved homeostatic constraints underlie the 
optimization of essential gene expression and highlights processes with divergent evolutionary 
pressures. Our findings thus provide both new insights into bacterial physiology and an 
important new tool for exploring reduced-expression phenotypes in many bacterial species. 
 
RESULTS AND DISCUSSION 
CRISPRi efficacy is similarly titrated by sgRNA mismatches in E. coli and B. subtilis 
Mismatched sgRNA efficacy has been sparsely tested in E. coli (Qi et al., 2013) using rfp 
targeted by variants of a single sgRNA. However, no comprehensive, multi-species 
measurements of repression by mismatched sgRNAs have been reported for bacterial 
CRISPRi. To directly quantify the impact of mismatches on the repression of mismatched 
sgRNAs in bacterial systems, we generated a comprehensive library of sgRNA spacers 
targeting gfp (3201 total), consisting of all spacers fully complementary to the non-template 
strand (33), a majority of their possible single mismatch variants (47/60), and a subset of their 
possible double mismatch variants (49/1710) (Figure 3.8A). Using FACS-seq (Figure 3.1A, 
Methods), we quantified the ability of these sgRNAs to repress transcription of a highly 
expressed chromosomal copy of gfp both in E. coli and B. subtilis (Figure 3.9A-C, Table S1). 
We found that sgRNAs with either single (Figure 3.1B) or double (Figure 3.10A) mismatches in 
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their base-pairing regions generated the full range of repression (no efficacy to full efficacy) in 
both species. Importantly, sgRNA activity was unimodal (Figure 3.9E-H) and highly correlated 
between E. coli and B. subtilis (R2: singly mismatched sgRNAs = 0.65, doubly mismatched 
sgRNAs = 0.61, all sgRNAs = 0.71; Figure 3.1B, Figure 3.10A, and Table S1), despite an 
evolutionary distance of several billion years and differences in experimental setup (E. coli: 
plasmid-encoded sgRNAs, B. subtilis: chromosomally integrated sgRNAs).  
Mismatched sgRNA efficacy has also been explored in mammalian CRISPRi systems 
(Gilbert et al., 2014; Jost et al., 2020), however, substantial differences exist between CRISPRi 
modalities in bacteria (blocking RNA-polymerase elongation) and mammalian systems 
(recruiting chromatin modifiers to promoters). To compare mismatched sgRNA efficacy between 
bacteria and mammalian systems, we calculated the mean relative activity of bacterial gfp-
targeting and mammalian essential gene-targeting singly mismatched sgRNAs (Jost et al., 
2020) for all combinations of mismatch position and base substitution. We found that although 
sgRNA activity is correlated between the two systems (R2 = 0.61, Figure 3.1C and Figure 3.11), 
the activity of the mammalian system is more strongly impacted by mismatches in general, 
particularly in the PAM-proximal seed region (Figure 3.1C and Figure 3.11. Whereas almost all 
mismatches in the seed region completely abolish sgRNA activity in the mammalian system, 
sgRNAs with equivalent mismatches still retain measurable activity in the bacterial system, 
consistent with previous reports (Qi et al., 2013). These differences may be due to differences in 
how CRISPRi functions. In bacteria, dCas9 efficiently blocks transcriptional elongation when 
targeted within the ORF, while in mammalian systems, efficient repression requires targeting a 
dCas9-KRAB fusion to occlude the promoter region and recruit chromatic modifying proteins 
(Gilbert et al., 2013). Previous work compared the activity of mismatched sgRNAs in 
mammalian cells using either dCas9 or dCas9-KRAB (Gilbert et al., 2014) and found that 
mismatches in the seed region were better tolerated by a dCas9 repression system than by a 
dCas9-KRAB system. This indicates that KRAB function may be responsible for the sensitivity 
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of the mammalian system to mismatches. Taken together, these data suggest that although the 
primary determinant of mismatched sgRNA efficacy in both bacteria and mammalian systems is 
shared, differences in how CRISPRi functions in these two systems manifest as quantitative 
differences in mismatched sgRNA efficacy. Remarkably, mismatched sgRNAs function similarly 
in E. coli and B. subtilis, potentially allowing facile design of sgRNAs with specific degrees of 
knockdown across diverse bacterial systems.   
 
A species-independent linear model robustly predicts mismatched-sgRNA activity 
Given the species-independent performance of gfp-targeting mismatched sgRNAs, we 
next asked whether we could accurately predict the effects of single mismatches on sgRNA 
activity. Previous work on CRISPRi off-target effects (Gilbert et al., 2014; Qi et al., 2013) and 
concurrent work on mismatched sgRNAs in a mammalian context (Jost et al., 2020), identified 
mismatch position, base substitution, and the GC% of the fully complementary spacer as the 
strongest determinants of mismatched sgRNA efficacy. We therefore constructed a simple 
linear model that used one-hot encoded mismatch position (20 parameters), one-hot encoded 
base substitution (12 parameters), and spacer GC% (1 parameter) to predict the relative 
efficacy of mismatched gfp-targeting sgRNAs (Figure 3.2A).  
We separately trained this linear 33-parameter model on the E. coli, B. subtilis, or 
species-averaged relative efficacy of our 1,551 gfp-targeting singly mismatched sgRNAs. 
Regardless of which data was used for training, model weights for mismatch location, base 
substitution, and spacer GC% were similar (Figure 3.12, Table S2), could be used for cross-
prediction (Figure 3.13) and reflected known dCas9 behavior. Model weights for mismatch 
location indicated decreasing sgRNA efficacy for mismatches closer to the PAM (Figure 3.2B), 
as expected based on the mechanism of dCas9 binding and R-loop formation (Gong et al., 
2018). Model weights for base substitution were correlated (R2 = 0.60, p < 0.005) to the 
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changes in the free energy of sgRNA-DNA pairing (ΔΔG) caused by the base substitution 
(Figure 3.2C). Finally, the negative coefficient assigned to GC% suggests that sgRNAs with 
high GC% are more tolerant of mismatches, consistent with what has been found in a 
mammalian system (Jost et al., 2020). Despite the simplicity of this model, the effects of single 
mismatches were robustly predicted (Figure 3.2D, Figure 3.13, species-averaged R2 = 0.56, 11-
fold CV-MSE = 0.10 +/- 0.08). Additionally, when applied to doubly mismatched sgRNAs by 
assuming that mismatches independently affect sgRNA efficacy (as suggested in Qi et al., 
2013), our model accurately predicted the relative efficacy of these sgRNAs (species-averaged 
R2 = 0.53, Figure 3.10B).  
To validate a biophysical interpretation of our model, we took advantage of a previously 
published data set containing measured association rates (kon) of a dCas9-sgRNA complex to 
60 singly mismatched and 1130 doubly mismatched DNA sequences (Boyle et al., 2017). Re-
interpreting this data as sgRNA mismatches, we compared the measured association rates to 
the relative sgRNA activity predicted by our model for these orthogonal sgRNAs (Figure 3.2E, 
Figure 3.10C). Our predicted sgRNA activity was highly correlated (R2: single mismatches = 
0.71, double mismatches = 0.45) to the kon measured in this in vitro system, supporting the 
hypothesis that mismatched-CRISPRi functions by reducing the association rate of the dCas9-
sgRNA complex for the target DNA, likely by slowing R-loop formation (Gong et al., 2018). 
Taken together, these data strongly suggest that a simple linear model trained on the relative 
efficacy of our gfp-targeting singly mismatched sgRNA library can be used to design 
mismatched sgRNAs with a specific activity level targeting any gene.  
 
Measuring the fitness of libraries of mismatched sgRNAs in E. coli and B. subtilis  
Using our model of mismatched sgRNA activity, we designed a set of sgRNAs targeted 
to the essential gene complement of E. coli and B. subtilis (~300 genes in each species, Table 
S3) and predicted to have a range of activities. We generated large pooled libraries of strains in 
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which each essential gene is targeted by 100 sgRNAs (10 fully matched guides each with 9 
singly mismatched variants, Methods, Figure 3.8C) and compact libraries in which each 
essential gene is targeted by 11 sgRNAs. Additionally, for two well characterized essential 
genes encoding UDP-GlcNAc-1 carboxyvinyltransferase (E. coli: murA, B. subtilis: murAA), and 
dihydrofolate reductase (E. coli: folA, B. subtilis: dfrA), we generated comprehensive libraries (at 
least 47/60 single mismatch variants for each sgRNA within the gene, Methods, Figure 3.8B). 
The libraries were grown for 10 doublings, maintaining exponential phase through back-dilution 
(Figure 3.3A). We calculated the relative fitness (Kampmann et al., 2013; Rest et al., 2013) of 
each strain by comparing its relative abundance (quantified by next-generation sequencing of 
the sgRNA spacers) to the relative abundance of 1000 non-targeting sgRNAs at the start and 
end of each experiment (Methods, Table S3). Relative fitness is defined as the number of 
doublings of any strain relative to the number of wildtype doublings over the time course of the 
experiment. Strains with a relative fitness of 1 grow as well as wild-type; lower values imply 
slower growth. Relative fitness was highly reproducible in both species (R2 > 0.9, Figure 3.14A-
B) and was validated by orthogonal measurements of individual strain fitness (Figure 3.14C). 
Our relative fitness values for fully complementary guides were correlated with previously 
reported measurements (Rousset et al., 2018; Wang et al., 2018) but had greatly expanded 
dynamic range (Figure 3.14D-E) due to differences in experimental design. Whereas previous 
studies were optimized for determining essentiality by quantifying fitness over >15 generations, 
we optimized our experiments for an expanded dynamic range by quantifying fitness over 10 
generations and sequencing to greater depth. This expanded dynamic range enabled the 
quantification of strong fitness defects, including measurement of negative relative fitness, 
which indicates active depletion from the pool. CRISPRi targeting of 23 E. coli genes and 24 B. 
subtilis genes reproducibly (>5 sgRNAs/gene) caused negative relative fitness (Table S4). 
Consistent with an interpretation of negative relative fitness as lysis, a majority (15/24) of these 
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B. subtilis genes caused lysis (as assayed by microscopy) when targeted with a fully 
complementary sgRNA (Peters et al., 2016) (Table S4, Methods).  
 
Per gene expression-fitness relationships are robustly quantified using mismatched-
sgRNAs 
We next assessed whether comparing the activity of sgRNAs predicted from our model 
to their measured relative fitness would allow us to infer the expression-fitness relationships of 
essential genes. Inferring per gene expression-fitness relationships requires both that our gfp-
trained model accurately predicts relative sgRNA efficacy and that fully complementary sgRNAs 
have similar efficacy at all loci within a gene.  
We first tested the applicability of our gfp-trained model to sgRNAs targeting 
endogenous genes. Since repression of essential gene expression monotonically decreases 
cellular fitness, we reasoned that if our model is accurate, predicted sgRNA efficacy should be 
negatively correlated to relative fitness within a series of sgRNAs targeted to a specific locus. 
Consistent with this hypothesis, we found that predicted sgRNA activity within series was 
negatively correlated to the relative fitness of those strains in both E. coli (median r = -0.74, 
Figure 3.3B) and B. subtilis (median r = -0.86, Figure 3.3B), suggesting that relative sgRNA 
activity was correctly predicted. Weaker correlations in E. coli likely reflect variation in sgRNA 
plasmid copy number and/or E. coli specific effects (Cui et al., 2018). To further probe the 
generality of our model, we trained it on the relative fitness effects of our comprehensive 
mismatched sgRNA libraries (Figure 3.8B) targeting the essential endogenous dihydrofolate 
reductase genes: E. coli folA (1,525 sgRNAs) and B. subtilis dfrA (1,281 sgRNAs). Because 
dihydrofolate reductase abundance is linearly related to fitness above an initial threshold of 
activity (Bhattacharyya et al., 2016), we interpreted the fitness defects of strains containing 
mismatched sgRNAs targeting these genes as readouts of knockdown efficacy. We found that 
when trained on the folA or dfrA data, model weights (Figure 3.12) and performance (Figure 
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3.13) were similar to the gfp-trained model, suggesting that both our model of mismatched 
sgRNA efficacy and the parameters fit from the gfp data are broadly applicable.  
We next tested whether knockdown efficacy was consistent across targeted loci. 
Because our model predicts knockdown efficacy with respect to the fully complementary sgRNA 
(“relative knockdown efficacy”), it can be applied across sgRNA families to determine 
expression-fitness curves only if fully complementary sgRNAs achieve similar knockdown 
efficacy at all loci within a gene. Fully complementary sgRNAs targeting gfp and folA/dfrA 
showed limited variability that did not correlate with the location of the sgRNA (Figure 3.15). To 
determine if this pattern held true for other endogenous essential genes, we reasoned that 
differences in knockdown at different loci within a gene would manifest as differences in the 
fitness effect of fully complementary sgRNAs targeting the same gene (Figure 3.3C-D). 
Comparing the variability of the fitness effect of fully complementary sgRNAs targeting the same 
gene to the overall variability in the fitness effect of fully complementary sgRNAs using sum of 
squares, we found that within gene variability accounted for only 26.7% of total variability in E. 
coli and 18.6% of total variability in B. subtilis. This suggests that fully complementary sgRNAs 
targeting the same gene are substantially more similar with regards to their fitness outcomes 
than fully complementary sgRNAs as a whole, and supports the assumption that fully 
complementary sgRNAs targeting the same gene have similar levels of activity.  
Consistent with these outcomes, predicted sgRNA activity was negatively correlated with 
cellular fitness for all sgRNAs targeting the same gene in both E. coli (median r = -0.65, Figure 
3.3B) and B. subtilis (median r = -0.75, Figure 3.3B). Taken together, these analyses strongly 
suggest that we can accurately and sensitively probe the expression-fitness relationships of 
essential genes in E. coli and B. subtilis by comparing the predicted activity of mismatched 
sgRNAs to their measured fitness using a pooled screening approach. 
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Expression-fitness relationships are conserved within biological processes and between 
essential homologs 
Examining the essential gene expression-fitness relationships, we were struck by their 
diverse and gene-specific nature (Table S3). To quantitatively characterize these differences, 
we first binned the sgRNAs targeting each gene according to predicted sgRNA activity and 
calculated the median fitness within each bin (Methods, Figure 3.16A-B, and Table S5). Next, 
we used these simplified representations of per gene expression-fitness relationships to 
calculate pairwise distances between E. coli and B. subtilis essential genes. Within each 
organism, we found that the expression-fitness relationships of genes involved in the same 
biological process (whether defined by KEGG, GO biological process, or COG) were 
significantly more similar to each other than to those of genes involved in different biological 
processes, even when excluding gene pairs in the same operon to account for CRISPRi polarity 
(all p < 10-16, Methods). Inversely, clustering genes by the shape of their expression-fitness 
curves produced functional enrichments (Table S6) in both E. coli and B. subtilis. Finally, in a 
cross-species comparison, the expression-fitness curves of essential genes were, as a group, 
more similar (p < 10-10) to that of their homologs than to other genes in the opposing species. 
To eliminate the possibility that these similarities were the result of systemic biases in 
the prediction of mismatched sgRNA activity, we also performed these analyses using the 
average per gene fitness effect of fully complementary sgRNAs, which do not depend on our 
model of mismatched sgRNA activity. We found that the per gene fitness effects of fully 
complementary sgRNAs were also significantly more similar within biological processes (all p < 
10-16, Methods) than between biological processes. However, clustering solely by the per gene 
fitness effects of fully complementary sgRNAs produced fewer functional enrichments, and a 
less statistically significant similarity between E. coli and B. subtilis homologs (p < 10-6). Taken 
together, these data suggest that these expression-fitness curves are both biologically 
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meaningful and representative of deeply conserved homeostatic constraints on bacterial 
physiology. 
 
Expression-fitness relationships of biological processes 
To explore the conserved optimizations of bacterial essential gene expression, we 
examined three functional categories having similar expression-fitness relationships in E. coli 
and B. subtilis. CRISPRi targeting of essential cofactor biosynthesis genes (KEGG pathways 
under “Metabolism of cofactors and vitamins”) did not strongly affect fitness in either species 
after 10 generations (Figure 3.4A-B). This observation is consistent with the small-colony but 
non-culturable phenotype of essential cofactor biosynthesis gene deletions (Koo et al., 2017) 
and suggests that these cofactors and/or the enzymes producing them are present in excess of 
what is required for exponential growth. This buffer may be required to enable rapid shifts in 
metabolism in response to changing environmental conditions, similar to what has been 
proposed for the pentose-phosphate pathway (Christodoulou et al., 2018).  
The robustness of both bacteria to CRISPRi targeting of essential cofactor synthesis 
genes contrasts with the strong, approximately linear effect of targeting genes involved in 
translation (KEGG pathways under “Translation”, Figure 3.4C-D). Previous work has 
established a linear relationship between growth rate and the number of ribosomes per cell 
during exponential growth in E. coli, B. subtilis, and other bacteria (Borkowski et al., 2016; 
Schaechter et al., 1958; Scott et al., 2010). By linearly inhibiting ribosomal protein expression, 
we likely decrease the number of functional ribosomes, leading to a corresponding linear 
decrease in growth rate. Moreover, feedback to restore ribosomal protein expression is unlikely 
because most ribosomal proteins are negatively regulated by their excess relative to rRNA 
(Nomura et al., 1980; Scott et al., 2014). Depletion of translation factors has a similarly linear 
effect on growth rate, likely due to slowed elongation rate (Dai et al., 2016) as has been shown 
for some antibiotics that inhibit translation elongation (Scott et al., 2010). The conserved linear 
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relationship between the expression of proteins involved in translation and growth rate 
reinforces the universal importance of translational capacity for determining growth rate.  
CRISPRi targeting of genes involved in cytoplasmic peptidoglycan (PG) precursor 
synthesis (KEGG ko00550) also generated strong phenotypes in both species. However, in 
contrast to the linear expression-fitness relationship of genes involved in translation, PG 
synthesis genes exhibited bimodal fitness outcomes that depended on predicted sgRNA activity 
(Figure 3.4E-F). This bimodality is highlighted by the fitness outcomes of the comprehensive 
murA and murAA-targeting libraries, even when considered independently of predicted 
knockdown (Figure 3.16C-D). Cells tolerated partial repression of these genes without exhibiting 
a fitness defect. If expression was sufficiently repressed, these strains lysed (Table S4) as has 
been described for murA, murG, and mraY inhibition in E. coli (Fransen et al., 2017; Mengin-
Lecreulx et al., 1991; Zheng et al., 2008) and for murC, murD, and murG depletion in B. subtilis 
(Peters et al., 2016). To determine whether the bimodality observed for these genes was due to 
bimodal CRISPRi activity, we measured the ability of 18 mismatched sgRNAs to repress a 
murAA-gfp transcriptional fusion in B. subtilis. These measurements were conducted in a B. 
subtilis strain complemented with non-targeted murAA (Methods) to enable quantification of 
lethal levels of knockdown and to avoid the potential for transcriptional feedback. Measured 
knockdown closely tracked the predicted activity of sgRNAs targeting murAA in this experiment 
(Figure 3.16E, Table S10), suggesting that the non-linear expression-fitness relationship of 
uncomplemented murAA reflects non-linearly decreasing growth due to MurAA depletion, 
transcriptional feedback, cell lysis, or other host specific effects. Previous work in E. coli 
(Mengin-Lecreulx and van Heijenoort, 1985) and Salmonella typhimurium (Kahan et al., 1974) 
demonstrated that the levels of enzymes involved in cytoplasmic peptidoglycan precursor 
synthesis are not affected by growth rate or fosfomycin inhibition. Additionally, recent work in E. 
coli, Caulobacter crecentus, and Listeria monocytogenes (Harris and Theriot, 2016) found that 
low doses of fosfomycin impact cell morphology, as expected if peptidoglycan synthesis is 
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inhibited, but did not impact growth rate. This suggests that the absence of homeostatic 
regulation in peptidoglycan precursor synthesis is conserved.  Given this lack of regulation, the 
dearth of intermediate fitness outcomes in either species upon repression of PG precursor 
synthesis is surprising. It suggests that neither species is able to slow growth rate or up-regulate 
cytoplasmic PG precursor synthesis in response to reduced flux through this pathway to prevent 
lysis. It has been proposed that bacteria use peptidoglycan precursor concentration to sense 
and balance cellular metabolism and growth (Harris and Theriot, 2016). This would be 
incompatible with direct feedback regulation of cytoplasmic PG precursor synthesis and may 
explain the sharp transition between growth and lysis. 
 
The expression-fitness relationships of many cell wall synthesis genes differ between E. 
coli and B. subtilis  
Given the similarity between the expression-fitness curves of most essential genes in E. 
coli and B. subtilis, we reasoned that homologs with substantially different expression-fitness 
curves may reflect biologically meaningful differences between the two organisms. We identified 
9 homologs as significantly different between the two organisms (Table S7, FDR < 0.2).  
Remarkably, 7/9 of these genes encoded enzymes involved in peptidoglycan (PG) 
synthesis and maturation, highlighting that although these pathways are conserved between 
Gram-positive and -negative species, major distinctions have evolved in how they contribute to 
construction of viable cells. Whereas CRISPRi targeting of genes involved in cytoplasmic PG 
precursor synthesis (Figure 3.5, group 3) generated bimodal expression-fitness relationships in 
both E. coli and B, subtilis, CRISPRi targeting of genes encoding enzymes involved in UDP-
GlcNAc synthesis, meso-DAP synthesis, and longitudinal cell wall synthesis differentially 
affected the two species (Figure 3.5).  
E. coli was significantly more tolerant of mreBCD perturbation than B. subtilis (Figure 
3.5, group 4). In contrast to B. subtilis, which lysed at intermediate levels of mreBCD 
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knockdown, E. coli exhibited a minimal fitness defect after 10 generations and only lysed after 
15 generations (Table S3). This observation is consistent with the small effect of CRISPRi 
targeting of mrdA (the PBP2 associated with MreBCD) on fitness in E. coli, the lack of 
transcriptional knockdown when targeting mreC (Reis et al., 2019), and with previous work 
which found that the fitness of Enterobacter cloacae is also relatively unaffected by mreBCD 
CRISPRi targeting (Peters et al., 2019). It is unclear why E. coli and other Gram-negative 
bacteria are less affected by mreBCD CRISPRi targeting than B. subtilis, however 
transcriptional buffering through feedback appears to play a role.  
E. coli was also more robust than B. subtilis to CRISPRi targeting of genes required for 
producing either UDP-GlcNAc (Figure 3.5, group 1) or meso-DAP (Figure 3.5, group 2). 
Whereas B. subtilis lysed when these genes were targeted with high activity sgRNAs, E. coli 
exhibited a minimal fitness effect after 10 generations (Figure 3.5, Table S4, and Table S7). To 
determine whether transcriptional feedback, mediated by divergent regulatory mechanisms 
(Barreteau et al., 2008; Rodionov et al., 2003) is responsible for the lack of observed phenotype 
in E. coli, we measured the ability of 2 fully complementary and 2 mismatched sgRNAs to 
reduce the expression of E. coli genes encoding enzymes involved in meso-DAP (asd, dapD, 
dapE), and UDP-GlcNAc (glmS) synthesis using RT-qPCR. We found that both fully 
complementary and mismatched sgRNAs were effective in significantly reducing the expression 
of these genes, with mismatched sgRNAs affecting gene expression less than fully matched 
sgRNAs (Figure 3.6A). All fully complementary sgRNAs targeting dapD and dapE generated 
similar knockdown (~20 fold) to a sgRNA targeting rfp, suggesting that if compensatory 
mechanisms exist, they must be post-transcriptional. In contrast, fully complementary sgRNAs 
targeting asd and glmS were less efficacious, generating ~5 fold knockdown, suggesting that 
the robustness of E. coli to CRISPRi targeting of asd and glmS may be due to transcriptional 
feedback. Consistent with this hypothesis, asd, which encodes an important branchpoint 
enzyme in amino acid synthesis is multivalently repressed by lysine, threonine, and methionine 
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(Boy and Patte, 1972) and negatively regulated by the small RNA SgrS (Bobrovskyy and 
Vanderpool, 2016). By de-repressing asd in response to low amino acid levels, these 
mechanisms may be responsible for the increased robustness of E. coli to asd knockdown. 
Similarly, the robustness of E. coli to CRISPRi targeting of glmS may also be due to feedback 
regulation by a positively acting sRNA, glmZ, which stabilizes glmS mRNA in response to low 
intracellular GlcN-6-P levels (Urban and Vogel, 2008), such as those caused by CRISPRi 
targeting of glmS. Taken together these results suggest that feedback, mediated by divergent 
regulatory mechanisms (Barreteau et al., 2008; Rodionov et al., 2003) may contribute to the 
reduced sensitivity of E. coli to CRISPRi targeting of these genes. 
An additional difference between cell wall synthesis in E. coli and B. subtilis is PG 
recycling (Figure 3.6B). Whereas E. coli recycles cleaved PG in both exponential and stationary 
phase, B. subtilis does so only in stationary phase (Johnson et al., 2013). We reasoned that 
increased robustness of E. coli to knockdown of genes in meso-DAP and UDP-GlcNAc 
synthesis might be a consequence of the ability of E. coli to supplement de novo synthesis of 
these compounds with recycled PG. We therefore repeated our small library fitness experiments 
in E. coli strains harboring deletions of either ampG or mpl, two key enzymes involved in 
recycling, and compared the relative fitness of essential gene knockdowns in the different 
backgrounds (Methods, Figure 3.8C). AmpG is the sole permease involved in PG recycling, and 
its deletion abolishes PG recycling (Johnson et al., 2013). Deletion of ampG did not sensitize E. 
coli to knockdown of PG synthesis genes (Figure 3.6C), suggesting that recycled PG does not 
contribute robustness to knockdown. Surprisingly deletion of mpl, which acts downstream of 
AmpG to ligate salvaged tripeptides to UDP-GlcNAC, sensitized E. coli to knockdown of murI 
and dapA (Figure 3.6D). These two genes encode enzymes responsible for isomerizing L-Glu to 
D-Glu (murI) and catalyzing the rate limiting step in meso-DAP synthesis (dapA, Reverend et 
al., 1982). D-Glu and meso-DAP are two of the three amino acids in the tripeptide ligated by 
mpl. The sensitizing and specific effect of an mpl deletion suggests that the flux through PG 
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recycling is important for fitness, and the lack of sensitizing effects in the ampG deletion 
suggests that the absence of this flux can be overcome. Compensatory regulation in response 
to a cytoplasmic PG intermediate upstream of mpl ligation (e.g. UDP-GlcNAC) would be 
activated in response to ampG deletion, but not in response to mpl deletion, potentially 
explaining our observations. However, the mechanism of such regulation remains to be 
elucidated.  
These experiments also identified a novel phenotype, highlighting the ability of these 
approaches to generate new biology. Deleting either ampG or mpl de-sensitized E. coli to the 
depletion of FtsH (Figure 3.6C-D), an essential protease responsible for balancing flux through 
lipopolysaccharide biosynthesis and phospholipid synthesis by regulating the stability of LpxC, 
an enzyme catalyzing the first committed step in lipopolysaccharide synthesis (Ogura et al., 
1999). It remains to be determined whether PG recycling affects the balance between 
lipopolysaccharide biosynthesis and phospholipid synthesis (perhaps by depleting the pool of 
UDP-GlcNAc), or an ancillary FtsH function. Underscoring the importance of screening multiple 
levels of essential gene knockdown, no significant epistatic interactions were identified in either 
strain background when only the two fully complementary sgRNAs targeting each gene were 
considered. These data highlight the utility of combining mismatched CRISPRi libraries with 
other genetic backgrounds to identify novel modulators of essential gene requirements.  
 
Expression-fitness curves are modulated by external perturbations  
 Bacteria have been previously shown to produce some enzymes at higher levels than 
needed for immediate survival in order to buffer against future environmental perturbations 
(Figure 3.4A-B, Christodoulou et al., 2018). To explore the ability of mismatched sgRNAs to 
capture shifts in the expression-fitness relationship of individual genes driven by external 
perturbations, we measured the relative fitness of the comprehensive sgRNA library targeting 
drfA in B. subtilis treated with sub-MIC doses of the antibiotic trimethoprim. Trimethoprim 
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directly inhibits DfrA (Figure 3.7A) and has been shown to act synergistically with partial 
knockdown of dfrA (Peters et al., 2016). However, the degree of synergy as a function of dfrA 
knockdown has not been investigated. We found that a low dose of trimethoprim abolished the 
initial buffering observed in the untreated strain (Figure 3.7B). A higher (but still sub-MIC) dose 
of trimethoprim further depressed the expression-fitness relationship, and caused a phenotype 
even at the lowest levels of knockdown. These data suggest that the DfrA concentration is 
buffered against external perturbations and highlights the ability of mismatched sgRNAs to 
enable exploration of these subtle shifts.     
 
PERSPECTIVE 
Bacterial essentialomes typically consist of several hundred genes encoding the core 
reactions central to viability. Apart from studies of the lac operon (Dekel and Alon, 2005; Eames 
and Kortemme, 2012), the lack of precise, high-throughput methods for titrating gene 
expression has precluded an understanding of how bacteria respond to a continuum of essential 
gene repression. Here we report a modified CRISPRi system that generates graduated, 
species-independent levels of repression by programming dCas9 with singly mismatched 
sgRNAs. Leveraging this system, we assessed the fitness effects of titrating essential gene 
expression for almost all essential genes in E. coli and B. subtilis. These data revealed striking 
differences between the expression-fitness landscapes of genes and pathways that highlighted 
conserved and divergent biological constraints driving the optimization of essential gene 
expression. Because CRISPRi tools have now been established for many bacteria (e.g. (Peters 
et al., 2019), our approach can be applied to pathogenic and microbiome strains to inform target 
selection for drug design and illuminate unique constraints for bacterial growth.  
Our comprehensive characterization of mismatched sgRNAs targeting gfp identifies the 
organism-independent rules that determine mismatched sgRNA activity in bacteria (Figure 3.1 
and Figure 3.2). By applying these rules, either independently or with the software developed 
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here (Methods), sgRNAs can be readily designed that generate a specific level of knockdown 
targeting any bacterial gene. These mismatched sgRNAs enable a range of high-throughput 
techniques to accelerate biological discovery. First, mismatched sgRNAs allow the rapid 
generation of reduced expression mutants. Reduced expression mutants of essential genes 
have been used for drug target discovery and lead optimization in Mycobacterium tuberculosis; 
however, extensive up-front strain optimization was required to identify gene-specific expression 
levels that facilitate identification of chemical-genetic interactions (Johnson et al., 2019). Our 
system enables facile generation and testing of a broad range of repression levels, potentially 
accelerating drug discovery and target identification. Second, our high-throughput pooled 
screening methodology to determine relative fitness is amenable to testing the effects of 
essential gene titration in varying environmental and genetic backgrounds. To simplify the 
exploration of essential gene requirements in diverse conditions, we constructed smaller (11 
sgRNA/gene) libraries for E. coli and B. subtilis essential genes that can be easily screened in 
varying conditions or transferred into different genetic backgrounds. The reduced complexity of 
these libraries aids multiplexing while retaining a broad range of phenotypes for most genes in 
both species (Figure 3.17). Finally, our approach also allows the use of CRISPRi to measure 
epistatic interactions between essential and non-essential genes. This approach had previously 
been hampered by the need to fully repress the non-essential gene (so as to maximize the 
chance of a phenotype) while only partially repressing the essential gene (so as to enable cell 
survival). This hurdle can be overcome by targeting the essential gene with a mismatched 
sgRNA.  
Although a mounting body of evidence supports the idea that gene essentiality is a 
quantitative trait (Rancati et al., 2018), systematically exploring this hypothesis has been 
challenging due to the lack of universally applicable methods of essential gene titration. Here we 
firmly establish quantitatively different fitness effects of essential gene depletion by targeting 
each gene at 10 separate loci using directly comparable CRISPRi methodologies and fitness 
 92 
measurements in two species. This is the first dataset that allows meaningful comparisons of 
expression-fitness relationships across species, and we use it to compare homologous essential 
genes in E. coli and B. subtilis. The similarity of most expression-fitness relationships between 
these diverged species underscores conserved evolutionary constrains and also highlights the 
significant differences in DAP synthesis and in the Rod PG synthetic apparatus as new targets 
for study. In contrast to synthetic promoter-based methods of studying expression-fitness 
relationships (Keren et al., 2016) which inherently eliminate native transcriptional feedback 
loops, our method is sensitive to the effects of essential gene regulation. Whether a cell buffers 
the effects of gene repression by regulatory feedback or by producing an excess of gene 
product is secondary to the importance of having buffering capacity, which is readily observed 
for some genes and not others. These studies inform target selection for drug design, illuminate 
aspects of bacterial growth, and provide a starting point for investigating how bacteria program 
robustness into their essential gene network.  
 
MATERIALS AND METHODS 
 
Experimental model and subject details: 
Microbes 
Escherichia coli strains were cultured in LB medium at 37C. Bacillus subtilis strains were 
cultured in LB medium at 37C. 
 
Methods details: 
General strain manipulations and procedures 
Bacillus subtilis strain construction and growth conditions 
All B. subtilis strains were constructed in the wildtype 168 background using natural 
competence as previously described (Koo et al., 2017). For all individual CRISPRi strains and 
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libraries, a recipient strain encoding dcas9 under control of the Pxyl promoter at the lacA locus 
(strain CAG74209) (Peters et al., 2016), was transformed with an sgRNA plasmid (see “sgRNA 
plasmid construction”) which recombines in single copy at the amyE locus, selecting for 
chloramphenicol resistance. In select cases, single- vs. double-crossover events from plasmid 
integration were distinguished by streaking on starch plates to assay disruption of amyE. 
For the GFP knockdown FACS-seq experiments, two modified recipient strains expressing 
dcas9 were constructed: one encoding gfp (strain CAG78920) and the other encoding rfp (strain 
CAG78921). To construct these, the dcas9 strain (strain CAG74209) was transformed with 
pDG1731-gfp or pDG1731-rfp to integrate Pveg-gfp-spc or Pveg-rfp-spc, respectively, at the 
thrC locus, selecting for spectinomycin resistance. All subsequent transformations of the gfp 
and rfp-marked strains required threonine supplementation in the competence media (40μg/ml), 
as thrC is disrupted. 
For flow cytometry-based competition experiments (see “Relative fitness validation”), the 
dcas9 recipient strain was transformed with a modified sgRNA plasmid that also encodes either 
Pveg-gfp or Pveg-rfp (see “sgRNA plasmid construction”). 
A murAA-gfp transcriptional fusion knock-down reporter strain was constructed by 
transformation of the dcas9 strain (above) with the DNA fragments containing constitutively 
expressed rfp with removable kanR cassette, murAA-gfp transcriptional fusion with removable 
kanR cassette, and constitutively expressed non-targeted murAA with spectinomycin resistant 
gene, of which fragments were integrated into sacA, murAA and thrC locus respectively, 
sequentially in that order. The B. subtilis Pveg promoter was used for constitutive expression of 
rfp and non-targeted murAA. The DNA fragment containing constitutively expressed rfp with 
removable kanR cassette was constructed by joining PCR of three fragments: Pveg-rfp-kanR 
fragment amplified from pACYC-rfp-kanR, and 1kb each 5′ and 3′ flanking sequences of 
sacA. The DNA fragment containing murAA-gfp transcriptional fusion with removable kanR 
cassette was constructed by the joining of gfp-kanR amplified from pACYC-gfp-kanR, 1kb of the 
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3’ end of the murAA open reading frame, and 1kb downstream of the murAA open reading 
frame. Before the gfp-kanR fragment was integrated downstream of murAA to generate strain 
CAG78923, the kanR cassette was removed from rfp strain as described previously to generate 
strain CAG78922 (Koo et al., 2017). Non-targeted murAA was designed to remove PAM 
sequence or alter the sgRNA targeting sequence without substituting amino acid sequence of 
murAA. Non-targeted murAA DNA was generated by overlapping PCR with mutagenic primers 
(Table S8) and its BsiWI/NruI digested fragment were cloned into pJMP3 (Addgene #79875) 
digested with BsrGI/PmeI. The cloned plasmid was transformed into the dcas9, rfp, murAA-gfp 
strain, selecting for spectinomycin resistance, to generate strain CAG78924. Finally, this strain 
was transformed with sgRNA plasmids as described above. 
Unless otherwise noted, all strain construction and growth assays for B. subtilis were done 
in LB medium and using antibiotics at the specified concentrations: erythromycin (1μg/ml), 
spectinomycin (100μg/ml), chloramphenicol (7.5μg/ml), kanamycin (7.5μg/ml). 
 
Escherichia coli strain construction and growth conditions 
All CRISPRi library strains were constructed in the wildtype BW25113 background by 
electroporating an sgRNA plasmid or plasmid pool (see “sgRNA plasmid construction”) into a 
recipient strain encoding dcas9 (for essential gene knockdown libraries), or dcas9 and gfp or rfp 
(for GFP knockdown libraries), selecting for ampicillin resistance. 
For the essential gene knockdown library recipient strain (strain CAG78830), Tn7 
transposition was used to integrate a dcas9 expression cassette into the Tn7att site using 
triparental mating of DAP(diaminopimelic acid)-dependent donors and selecting for gentamicin 
resistance in the absence of DAP, as previously described (Peters et al., 2019). The dcas9 
expression cassette is modified from previously described versions (Peters et al., 2019), 
contains dcas9 from S. pyogenes (Qi et al., 2013) with a 3X Myc C-terminal tag, and is 
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expressed from the IPTG-inducible promoter PlLac-O1 (Lutz and Bujard, 1997) and regulated 
by lacIq. 
For the GFP knockdown FACS-seq experiments, two recipient strains expressing dcas9 
were constructed: one encoding gfp (strain CAG78108) and the other encoding rfp (strain 
CAG78107). Each was generated by first cloning the constitutive gfp and rfp expression 
cassettes from pDG1731-gfp and pDG1731-rfp upstream of frt-cat-frt from pKD3 (Datsenko and 
Wanner, 2000), integrating them into the chromosome between yjaA and yjaB using 
recombineering (Thomason et al., 2014), and selecting for chloramphenicol resistance. P1 
phage transduction (Thomason et al., 2007) was then used to move the gfp-frt-cat-frt or rfp-frt-
cat-frt cassettes into BW25113, selecting for chloramphenicol resistance. Chromosomal dcas9 
was then introduced to these strains by conjugation using a pseudo-Hfr dcas9 donor, as 
described previously (Rauch et al., 2017), where dcas9 is expressed by the minimal synthetic 
promoter PBBa_J23105 {https://parts.igem.org}, and transconjugates were selected using 
gentamicin and chloramphenicol. 
For the RT-qPCR experiments, CRISPRi strains expressing sgRNAs targeting 
peptidoglycan biosynthesis genes were individually reconstructed by electroporating the dcas9 
strain (strain CAG78830) with sgRNA plasmids constructed as described below (see “sgRNA 
plasmid construction”). 
For the experiments combining the compact sgRNA libraries with deletions of peptidoglycan 
recycling pathway genes, the desired deletion alleles (ampG::kan or mpl::kan) were isolated 
from the Keio collection. Briefly, the deletion mutants were isolated, confirmed by PCR of 
kanamycin cassette junctions, and P1 phage was made from verified strains. Transduction of 
the dcas9 strain (strain CAG78830) was performed (Thomason et al., 2007) with each the 
phage, selecting for kanamycin resistance, and the resulting strains were transformed with 
sgRNA plasmid libraries as detailed below (see “Escherichia coli CRISPRi library construction) 
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Unless otherwise noted, all strain construction and growth assays for E. coli were done in 
LB medium and using antibiotic selection at the specified concentrations: ampicillin (100μg/ml), 
carbenicillin (50μg/ml), gentamicin (10μg/ml), chloramphenicol (25μg/ml), kanamycin (30ug/ml). 
 
Bacillus subtilis CRISPRi library construction 
As in the individual CRISPRi strain construction (above), CRISPRi libraries were constructed by 
transforming sgRNA plasmids into the dcas9 strain. The protocol was modified in one of two 
ways in order to increase the scale; we found both methods were sufficient to maintain 
coverage of the pooled plasmids. In one method, cells were grown in B. subtilis competence 
medium to OD600=1.5, and then incubated with plasmid DNA (300μl cells + 300ng plasmid 
DNA) in 96-well deep-well plates. Incubations were performed for 2hr at 37C with shaking 
(900RPM), after which point plates were spun down at 5000g for 10 minutes and resuspended 
in 2mL LB medium before plating on plates (Falcon #351058) with chloramphenicol at a density 
~0.4M CFU/plate and growth overnight at 37C. A second method incubated competent cells 
(grown in B. subtilis competence medium to OD600=1.5) with plasmid DNA in culture flasks, for 
2hr at 37C with shaking (900RPM), after which point cells were spun down in 50ml tubes and 
resuspended in 2-6ml LB before plating on chloramphenicol plates as before. 
To store the transformed CRISPRi library, plates were scraped, pelleted and resuspended in 
S7 salts (Koo et al., 2017) with 15% glycerol, and stored in 500uL aliquots at -80C. 
 
Escherichia coli CRISPRi library construction 
Strain library construction from plasmid libraries was achieved by electroporating plasmid DNA 
into the recipient strains, and plating on plates (Falcon #351058) with carbenicillin and 0.2% 
glucose (to repress uptake of residual lactose in LB that can induce the IPTG-controlled dcas9 
in the essential gene knockdown strains) at a density ~0.4M CFU/plate and growth overnight at 
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37C. To store the libraries, plates were scraped, pelleted, and resuspended in 15% glycerol to 
be stored at -80C. 
 
sgRNA plasmid construction 
The sgRNA plasmid pJSHA77 was modified from pDG1622 to increase transformation and 
double-crossover efficiency. 1.5kb of DNA upstream of amyE was PCR amplified from B. 
subtilis 168 genomic DNA and inserted into pDG1662 by HiFi Assembly (New England Biolabs 
#E2621L), replacing the shorter upstream fragment of amyE in pDG1662. Synthetic DNA 
containing a transcription terminator, an sgRNA driven by Pveg with BsaI cut sites for spacer 
cloning, and downstream tandem transcription terminators was purchased from IDT and cloned 
into the previously described pDG1662 derivative by HiFi Assembly (New England Biolabs 
#E2621L), generating pJSHA77. 
Oligonucleotide pools containing the desired elements with flanking restriction sites and 
library-specific PCR adapters were obtained from Agilent Technologies (Table S8). The 
oligonucleotide pools were amplified by 15 cycles of PCR using Q5 polymerase (New England 
Biolabs #M0493S) and custom primers (Table S8). The PCR product was digested with BsaI-
HFv2 (New England Biolabs #R3733) and gel purified from 10% TBE gels (Invitrogen 
#EC6275BOX) to remove adapter ends. pJSHA77 vector was midi-prepped (Qiagen #12143), 
digested with BsaI-HFv2 for 1hr, and treated with Antarctic phosphatase (New England Biolabs 
# M0289S), and ligation was carried out at a 1:2 (vector:insert) molar ratio using T4 DNA Ligase 
(New England Biolabs #M0202L). Ligations were transformed into electrocompetent cells (New 
England Biolabs #C3020K), recovered for 1hr at 37C in LB, and then inoculated into 100ml with 
carbenicillin and grown overnight. Plasmid libraries were collected by midiprep (Qiagen #12143) 
and analyzed by deep sequencing (Illumina MiSeq #MS-103-1002) to assess cloning efficiency 
and library diversity.  
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For individual sgRNA strains, inserts were prepared by annealing two single-stranded DNA 
oligos together to create the 4-base overhangs, and then annealed inserts were ligated using T4 
DNA Ligase (New England Biolabs #M0202L) individually into pJSHA77 digested with BsaI-
HFv2 and treated with Antarctic phosphatase (New England Biolabs # M0289S). 
For the single-strain competition validation strains, pJSHA77 was first modified to 
incorporate a constitutively expressed Pveg-gfp or Pveg-rfp using HiFi Assembly (New England 
Biolabs #E2621L). Strains were then constructed as described above, ligating annealed-pair 
inserts into the modified vector after digesting with BsaI-HFv2. 
 
sgRNA plasmid library design  
Code for designing (fully matched) sgRNA spacers targeting a list of genomic loci can be found 
at https://github.com/traeki/sgrna_design.  
Non-targeting sgRNA controls were designed by creating random 20nt sequences with a 
distribution of GC content similar to B. subtilis (~45%), and then using bowtie (Langmead et al., 
2009) to identify (and subsequently filter out) sgRNAs which aligned (allowing 3 or fewer 
mismatches) to other intragenic targets in the combined genomes of E. coli and B. subtilis, or 
any targets in gfp or rfp. 
For the libraries targeting all essential genes in B. subtilis, multiple iterations of sgRNA 
library design (i.e. spacer design), construction, and analysis were used. For B. subtilis libraries, 
all presented data is from V2 library measurements, with the exception of the trimethoprim 
experiments which used measurements of the V1 libraries (all data in Table S3). 
For the V1 libraries targeting B. subtilis genes we chose target genes to be all those 
previously identified as essential, putative essential, or low-fitness (Koo et al., 2017; Peters et 
al., 2016) (Table S3). For every gene in the V1 set, two non-overlapping fully complementary 
spacers were chosen, each targeting the non-template strand as close to the start of the ORF 
as possible. For each fully complementary spacer, a set of 25 spacer variants were designed 
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and ordered: 2x the fully complementary spacer, 5x randomly chosen single-mismatches within 
7 bases of the PAM, 5x randomly chosen single-mismatches 8-12 bases from the PAM, 3x 
randomly chosen single-mismatches 13-19 bases from the PAM (to exclude the outermost 
base), 10x randomly chosen double mismatches 1-19 bases from the PAM. In addition, for 
every gene the first three non-overlapping template-strand spacers were included. 
The V2 B. subtilis libraries included all essential B. subtilis genes as well as a subset of non-
essential but fitness-impacting genes (Table S3) from V1 of the library. The V2 E. coli libraries 
included a majority of genes with evidence for essentiality (Table S3) (Koo et al., 2017). For 
every gene in this set, ten non-overlapping fully complementary spacers were chosen on the 
non-template strand, as close to the start of the ORF as possible. For each fully complementary 
spacer, a set of 10 spacer variants was designed and ordered (for a total of 100 sgRNAs per 
gene): 1x the original fully complementary spacer, 9x single-mismatches (Figure 3.8). Single-
mismatches were chosen using the following criteria: all possible single-mismatch variants were 
evaluated by the trained linear model for a predicted sgRNA activity (GitHub - 
traeki/sgrna_design, no date) (train_linear_model.py and choose_guides.py). These predicted 
sgRNA activities were categorized into five bins: <10%, >90%, and three equally sized bins 
between 10% and 90% predicted sgRNA activity. Three sgRNAs were chosen from each of the 
middle three bins.     For the design of all libraries using this strategy, a preliminary version of 
the linear model was used. 
The compact libraries with 11 sgRNAs per gene were selected as above, with the following 
modifications for both species: for each gene 2x fully complementary sgRNAs were chosen, and 
9x single-mismatch variants were selected from among all possible single-mismatch variants of 
each, using a binning strategy as described above (Figure 3.8). For E. coli, also as described 
above, the bins were generated using predicted sgRNA activity. For B. subtilis the bins were 
instead generated using the measured relative fitness values from the V1 experiment, and the 
selected sgRNAs were therefore a subset of those used in the V1 library. 
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The dfrA, gfp, and rfp V1 comprehensive libraries (used in the trimethoprim experiment and 
all FACS-seq experiments) were designed analogous to the V1 essential gene libraries, with 
100 sgRNAs per target: 4x the original fully complementary spacer, 20x randomly chosen 
single-mismatches within 7 bases of the PAM, 15x randomly chosen single-mismatches 8-12 
bases from the PAM, 12x randomly chosen single-mismatches 13-20 bases from the PAM, and 
49x randomly chosen double mismatches 1-20 bases from the PAM (Figure 3.8). 
For the V2 comprehensive libraries targeting dfrA, murAA, folA, or murA, we designed all 
possible non-template spacers, each with all possible single-mismatches, for a total of 60x 
mismatch variants per fully complementary sgRNA. 
 
Relative fitness experiments 
Relative fitness experimental details 
Glycerol stocks of the B. subtilis essential-gene library (V1 or V2), the dfrA and murAA libraries 
(V1 or V2), and the library of non-targeting control sgRNAs were fully thawed, mixed,  and 
inoculated into 150 mL cultures of LB at a combined OD600 of 0.01 (5% control, 75% essential-
gene library, 10% dfrA library, 10% murAA library). This culture was allowed to grow to OD600 
0.1, at which point the culture was back-diluted to OD600 0.01 in fresh 150 mL culture of LB + 
1% xylose. This culture was then grown to OD600 0.3 (~5 doublings), back-diluted to OD600 
0.01 in LB + 1% xylose, and grown to OD600 0.3 (total ~10 doublings). Samples were collected 
a) immediately before back dilution into xylose and b) after the final growth phase, ~10 
doublings apart (Figure. 2A). The trimethoprim experiments were carried out in an identical 
manner, except that both 1% xylose and trimethoprim (Sigma-Aldrich #T7883-5G) (0 ng/mL, 
15ng/mL, or 30ng/mL) were added from the first back-dilution and maintained throughout 
growth. Concentrations of trimethoprim were chosen such that wildtype growth rate was 
unaffected. 
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Fitness experiments for the E. coli V2 libraries were carried out in an identical manner to 
the B. subtilis fitness experiments with the following exceptions: all growth occurred in the 
presence of ampicillin, and induction was achieved with 1mM IPTG instead of 1% xylose. 
For both B. subtilis and E. coli, compact library experiments were carried out in an 
identical manner as the larger scale fitness experiments above, save that the volume of cultures 
was 15mL, and only compact libraries and non-targeting control libraries were mixed together 
(90% compact library, 10% controls). 
At the desired time points, B. subtilis cultures were collected (1ml) by pelleting (9000xg 
2min) and genomic DNA was extracted using the DNeasy Blood & Tissue kit (Qiagen #69506) 
with the recommended Gram-positive pre-treatment and RNAse A treatment. For the E. coli 
fitness experiments, E. coli cultures were collected (4ml) by pelleting (20000xg 2min) and 
plasmid DNA was extracted using the QIAprep Spin miniprep kit (Qiagen #27106). sgRNA 
spacer sequences were amplified from gDNA or plasmid DNA using Q5 polymerase (New 
England Biolabs #M0493S) for 14x cycles using custom primers containing TruSeq adapters 
and indices (Table S8), followed by gel-purification from 8% TBE gels (Invitrogen 
#EC62152BOX), and sequencing on HiSeq 4000 with single-end 50bp reads at the UCSF 
Center for Advanced Technology using a custom sequencing primer (Table S8). 
 
Relative fitness analysis 
Raw FASTQ files were aligned to the library oligos and counted using (GitHub - 
traeki/sgrna_design, no date) (count_guides.py), and relative fitness was calculated using 
(compute_gammas.py and gamma_to_relfit.py). For each strain (x) with at least 100 counts at t0 
we calculate the relative fitness F(x) according to: 
 
𝐹(𝑥) = 𝑙𝑜𝑔2 𝑟+,(𝑡.) ∗ 𝑟0(𝑡1.)𝑟+,(𝑡1.) ∗ 𝑟0(𝑡.)𝑔+, + 1 
 102 
 
where rx(ti) is the fraction of strain X in the population at time i and gwt is the number of 
generations of wildtype growth in the experiment. A derivation of this equation can be found in 
(Keren et al., 2016) and (Rest et al., 2013). In our experiments, gwt is calculated from the OD 
measurements of the culture, and rwt(ti) is calculated as the median of 1000 non-targeting 
control sgRNAs from that sample. For strains with at least 100 counts at t0 and 0 counts at t10, 
we set: 
 
𝑙𝑜𝑔2 𝑟0(𝑡1.)𝑟0(𝑡.) = 0 
 
Finally, the relative fitness measurements of each sgRNA were averaged across 
samples (B. subtilis experiments: 6 replicates, E. coli experiments: 4 replicates) to calculate the 
final relative fitness value and standard deviation (Table S3). 
 
Detection limits of relative fitness measurements 
Our relative fitness experiments seek to quantify the number of doublings each strain 
experiences during the course of the experiment, relative to the number of doublings a wild-type 
(or a non-targeting sgRNA control) strain experiences during this time. To do so, we measure 
the bulk growth of the population, and quantify the relative abundance of each strain at the start 
and end of each experiment via next-generation sequencing. Changes in the relative 
abundance of a strain are determined by the growth rate of the individual strain relative to the 
population as a hole. For example, there is a 210 ~ 1,000-fold increase in the number of cells 
during a 10-doubling experiment. Therefore, cells that do not divide (but remain intact) will 
experience a 1,000-fold decrease in relative abundance.  
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Our ability to measure the relative abundance of strains is constrained by sequencing 
depth.  Assuming an equal number of reads at the start and end of the experiment, 
measurement of a 1,000-fold decrease in relative abundance requires that a strain have at least 
1,000 reads at the start of the experiment. A poorly represented strain (e.g. 50 read counts at 
the start of the experiment) cannot decrease 1,000-fold and be meaningfully measured.  
Previously reported pooled fitness experiments of CRISPRi libraries in E. coli prioritized 
sensitivity to slight growth defects over quantifying the extent of a strong fitness defect (Figure 
3.13D-E). To do so, these experiments were run for many generations (15+) and were 
sequenced with relatively less depth (median counts ~100). This limited their ability to quantify 
strong fitness effects. In contrast, this study prioritized quantification of the full range of possible 
fitness outcomes. As a result, our experiments were run for 10 generations and deeply 
sequenced (median counts > 1,000), allowing us to quantify a broad range of fitness defects. 
Many strains were abundant enough at the start of the experiment to allow accurate 
quantification of decreases greater than 210 ~ 1,000-fold. These events (relative fitness < 0) 
represent active depletion from the pool. 
 
Relative fitness validation 
To validate the practice of using pooled growth measurements as an approximation of relative 
fitness, we also measured the relative fitness of individual dfrA knockdown strains grown in the 
presence of a wildtype strain. For each dfrA sgRNA, the spacer was cloned separately into 
pJSHA77-gfp and pJSHA77-rfp, each transformed into the dcas9 strain, and then competed 
against a wildtype constitutively expressing the opposite fluorophore (i.e. strains with a dfrA 
sgRNA and expressing gfp were competed against a wildtype expressing rfp). Strains were 
mixed at a starting OD600 of 0.01 in 300μL of LB in four replicate wells of a 96-well deep-well 
plate, covered with a breathable film, and grown shaking at 900 RPM at 37C. Cells were diluted 
to OD600 0.01 in fresh LB with 1% xylose and grown again (900 RPM, 37C) to OD600 0.3. 
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Immediately after each back-dilution (and at end of experiment) the previous plate was fixed 
with 50μL of 37% formaldehyde per well, incubated for 10min at room temperature, and 
quenched with 50μL of 2.5 M glycine. The quenched reaction was diluted 1:20 into 1X PBS 
before measurement by flow cytometry (LSRII, BD Biosciences) using the blue laser (488 nm) 
and the FITC detector (530/30 nm) for GFP detection, and the yellow/green laser (561 nm) and 
the PE-Texas Red detector (610/20 nm) for RFP detection. Data for at least 20,000 cells were 
collected, and thresholds based on control wells were used to define the GFP+ and RFP+ 
populations to determine the ratio of each population in each sample using FlowJo (FlowJo, 
LLC). All calculated relative fitness measurements from this validation experiment are provided 
in Table S3. 
 
Relative expression measurements 
Growth and RT-qPCR 
Reconstructed E. coli CRISPRi strains targeting genes involved in peptidoglycan precursor 
biosynthesis were grown in triplicate from single colonies in pre-warmed 4ml LB + ampicillin for 
2.5hrs before back-dilution (1:80) in pre-warmed 4ml LB + ampicillin + 1mM IPTG and growth 
for 3hr prior to collection (OD600 ~ 0.2). The control strains express rfp and harbor sgRNA 
plasmids expressing sgRNAs targeting either rfp or gfp (“non-targeting”) and were treated 
identically. Samples were collected (300ul) in 900ul TRIzol-LS (Thermo Fisher #10296010) and 
stored at -20C overnight. The following day RNA was extracted according to the TRIzol 
protocol. RNA was quantified using a NanoDrop 2000c Spectrophotometer (Thermo Scientific) 
to normalize input (500ng input / 20ul reaction). For each RT-qPCR probe set and each sample 
replicate, reactions were performed in triplicate. 
All RT-qPCR assays were done using the Luna Universal One-Step RT-qPCR kit (New 
England Biolabs #E3005S) according to its RT and cycling protocols, in 96 well PCR plates 
(Neptune #3732.X) and measured on a CFX Connect Real-Time System (Bio-Rad). 
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RT-qPCR analysis 
Standard curves for each primer pair were first assessed on serially diluted RNA (extracted from 
the CRISPRi control strain) to confirm single melting peaks, strong correlations of technical 
replicates, and to calculate their efficiencies (in accordance with (Bustin et al., 2009)). The 
relative expression (or Normalized Relative Quantity (NRQ)) of each gene of interest in each 
experimental sample was calculated according to (Hellemans et al., 2007), which uses the 
geometric mean of two reference genes (here: atpB and recA) to normalize the probe of interest 
within each sample, and further calculates the fold-change in relative expression compared to a 
wildtype strain. The “non-targeting” rfp+ strain was considered the wildtype for the normalization 
of all other strains. 
 
 
FACS-seq experiments 
FACS-seq experimental details 
Three separate strain libraries were constructed and mixed together for use in the sorting 
experiments: a gfp+ strain with the gfp-targeting sgRNA library (mismatch-GFP), a gfp+ strain 
with the non-targeting sgRNA control library (“high-GFP” or “control sgRNA” in figure), and a 
gfp- strain with the rfp-targeting sgRNA library (“no-GFP” or “dark control”) (Figure 3.1A). 
Glycerol stocks of each library were fully thawed, inoculated into replicate 12.5ml cultures of LB 
(B. subtilis) or LB with ampicillin (E. coli) at 0.01 OD600, and allowed to grow for 2.5-3hr. Then 
cultures were back-diluted to 0.01 OD600 in LB with 1% xylose (B. subtilis) or LB with ampicillin 
(E. coli) and grown for 2.5hr. Immediately before sorting the cultures were mixed at a ratio 
reflecting the overall diversities of their libraries (40% mismatch-GFP, 40% low-GFP, 20% high-
GFP), and then the mixture was diluted 1:10 in PBS at room temperature (B. subtilis) or on ice 
(E. coli).  
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Sorting was done on the mixed cultures using a BD FACSAria II (Laboratory for Cell 
Analysis in Helen Diller Family Comprehensive Cancer Center at UCSF), using the blue laser 
(488 nm) and the FITC detector (530/30 nm), and at a flow rate of 5 and collecting for 20min 
total. Post-sorting the collected bins were filtered using either cellulose nitrate membranes with 
0.2um pore (Thermo Scientific #145-0020) or mixed cellulose esters 0.22um pore disc filters 
(MF-Millipore #GSWP02500) on a glass filtration apparatus. Filters were resuspended in 9ml LB 
(B. subtilis) or LB with ampicillin (E. coli) by vortexing at max speed for 30s, then split into two 
outgrowth cultures and grown overnight in 4ml LB (B. subtilis) or LB with ampicillin (E. coli). A 
portion of the input mixed sample (i.e. pre-sorting) was treated similarly and grown overnight. 
DNA was extracted from each outgrowth culture separately and analyzed by deep sequencing 
as described above. 
 
FACS-seq analysis 
For each species, two biological replicates (i.e. cultures starting from unique glycerol stocks) 
were sorted by FACS, and from each biological replicate’s 4 bins (plus unsorted mixture) two 
technical replicates (i.e. two overnight outgrowth cultures from which DNA was extracted) were 
sequenced. Library spacers were counted in each sequenced sample, normalized to the 
sample’s total number of spacers counted, and technical replicate normalized counts were 
added together. For each biological replicate, the sorted bins were further normalized with 
respect to the mixed (i.e. pre-sorting) sample in the following manner: a linear model was used 
to determine the appropriate weights for each bin in order to recapitulate the mixed sample, and 
those weights were applied as scaling factors for all read counts from the given bin. This 
normalization was essential to correct for sequencing depth and cell number differences 
between bins. Briefly, we used the sklearn package (sklearn.linear_model) in Python and 
applied it to the mixed sample after removing from it the top and bottom 5th percentiles.  
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We sought to define a metric for enrichment in the GFP-high bins vs. the GFP-low bins 
that would be similar in scale to relative fitness. We define an enrichment ratio (ER) for each 
sgRNA as: 
 
𝐸𝑅 = 33𝑛. 𝑛𝑜𝑟𝑚;<=> + 23 ∗ 𝑛. 𝑛𝑜𝑟𝑚;<=? 13 ∗ 𝑛. 𝑛𝑜𝑟𝑚;<=@ + 03 ∗ 𝑛. 𝑛𝑜𝑟𝑚;<=1 
 
where n.normBin i is the normalized counts in Bin i, and Bin1 has the lowest GFP fluorescence 
while Bin4 has the highest. By this metric, values close to 1 have the highest GFP fluorescence 
(or weakest sgRNA activity) and values <1 have lower GFP fluorescence (or stronger sgRNA 
activity). Enrichment scores were normalized on a per experiment basis by subtracting the 
mean enrichment score of the “dark controls” and dividing by the mean enrichment score of the 
“high-GFP” strains. The resulting scores for each sgRNA (called the “FACS-seq score” in the 
main text) are available in Table S1. 
 
FACS-seq validation 
To validate our sorting procedure and the relationship between the calculated FACS-seq score 
and the fluorescence of a single strain, we randomly isolated 9 strains from the E. coli GFP 
knockdown library and analyzed them by flow cytometry to quantify knockdown relative to a 
non-targeting sgRNA (Figure 3.9E-H). Strains were grown in deep 96-well plates in 300ul LB 
overnight, diluted back and grown to ~0.4 OD600 before measurement. Briefly, data was 
collected on a LSRII flow cytometer (BD Biosciences) using the blue laser (488 nm) and the 
FITC detector (530/30 nm). Data for at least 20,000 cells were collected, and median 
fluorescence values were extracted using FlowJo (FlowJo, LLC). Data from representative 
samples were plotted as histograms using FlowJo to confirm that single-cell fluorescence was 
unimodal within the population (Figure 3.9E-H). sgRNA plasmids were miniprepped (Qiagen 
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#27106) from each library isolate and Sanger sequenced to ascertain their identity in the library 
experiment. To assay the behavior of the same sgRNAs in B. subtilis, the miniprepped plasmid 
was transformed into B. subtilis as described above, double-crossover events were verified by 
streaking on starch plates, and the strains were analyzed by flow cytometry as described above. 
All relative fluorescence measurements are provided in Table S1 and plotted in Figure 3.9A. 
 
Predicted sgRNA activity validation 
To validate the linear model’s ability to predict sgRNA activity based on sgRNA sequence, we 
measured the knockdown of a murAA-gfp transcriptional fusion in a B. subtilis strain that was 
complemented by a non-targeted copy of murAA. These strains also expressed a chromosomal 
rfp that allowed for calculation of the GFP/RFP ratio on a per cell basis. Strains were grown as 
described above (FACS-seq validation), with the exception that dcas9 was induced using 1% 
xylose after dilution. Data was collected on a LSRII flow cytometer (BD Biosciences) using the 
blue laser (488 nm) and the FITC detector (530/30 nm) for GFP detection, and the yellow/green 
laser (561 nm) and the PE-Texas Red detector (610/20 nm) for RFP detection. Data for at least 
20,000 cells were collected, and the per-cell GFP/RFP ratios as well as the population median 
GFP/RFP ratios were extracted using FlowJo (FlowJo, LLC). Relative knockdown was 
normalized to a murAA-gfp strain lacking an sgRNA, after first subtracting the background GFP 
fluorescence from a non-fluorescent B. subtilis strain. Relative GFP fluorescence 
measurements are provided in Table S9. 
 
Linear model of singly mismatched sgRNA efficacy 
Having measured the ability of ~1,600 singly mismatched sgRNAs to knockdown GFP 
expression, we sought to build a model to predict the effect of mismatches on sgRNA efficacy. 
Since an enrichment score of 1 represent maximal GFP fluorescence, and a score of 0 
represents no GFP fluorescence, we define knockdown for each sgRNA as: 
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 𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛EFGHI = 1 − 𝐹𝐴𝐶𝑆. 𝑠𝑒𝑞𝑠𝑐𝑜𝑟𝑒 
 
We then normalized the ability of each mismatched sgRNA to knockdown GFP compared to its 
equivalent fully complementary sgRNA using the equation below: 
 
𝑠𝑔𝑅𝑁𝐴𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦E<=FVWX<EXY,Z[\]EFGHI = 𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛E<=FVWX<EXY,Z[\]EFGHI𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛^_VVWZ`XaV\X\=,YbWEFGHI 
 
We next built a model that fit the activity of each sgRNA using the position of the 
mismatch (from 0 to 19, with 19 being PAM proximal, one hot encoded), the transition of the 
mismatch (from X to Y, one hot encoded), and the GC% of the fully complementary sgRNA. 
Mismatched sgRNAs were excluded from the analysis if they were variants of fully 
complementary sgRNAs with less than 0.5 knockdown (as described above). The parameters 
from this model trained on E. coli, B. subtilis, or species-averaged per sgRNA activity are 
presented in Table S2 and Figure 3.12, the raw data in Table S1. 
 
Expression-fitness relationship analysis 
Quantifying similarity between fully complementary guides targeting the same gene 
Our gfp based model predicts the activity of singly mismatched sgRNAs relative to the activity of 
the fully complementary sgRNA from which they are derived. To use this relative sgRNA activity 
as a proxy for absolute activity, fully complementary sgRNAs targeting the same gene should 
have the same activity. Since we cannot easily measure the sgRNA activity directly when 
targeting endogenous essential genes, we reasoned that we could validate this assumption by 
comparing fitness effect of fully complementary sgRNAs targeting the same gene (plotted in 
Figure 3.14).  
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To determine whether fully complementary sgRNAs targeting the same essential gene 
had similar effects, we compared the total sum of squares (totalSS) to the within gene sum of 
squares (withinSS) for fully complementary sgRNAs targeting essential genes. In E. coli, the 
withinSS accounted for 26.7% of the totalSS and in B. subtilis the withinSS accounted for 18.6% 
of the totalSS. This suggests that fully complementary sgRNAs targeting the same gene are 
substantially more similar with regards to their fitness outcomes than fully complementary 
sgRNAs as a whole, and supports the assumption that fully complementary sgRNAs targeting 
the same gene have similar levels of activity. 
 
Expression-fitness relationship analysis details  
In order to quantitatively assess the expression-fitness relationship of genes targeted by the V2 
E. coli and B. subtilis libraries, we developed a per gene pipeline, described below.  
 
1. In general, fully complementary sgRNAs targeting the same gene had similar fitness effects 
(Figure 3.17), suggesting that all fully complementary sgRNAs induce a similar level of 
knockdown. We identified outlier sgRNAs that were significantly less effective at inducing a 
fitness defect (and therefore were likely to be ineffective at knocking down their target) by 
comparing the distribution of fitness values for each series (series = the fully 
complementary sgRNA and its 9 singly mismatched variants) to the fitness distribution of 
the remaining series targeting the same gene. Using a two-sided t-test, we assessed 
whether the distribution of their relative fitness values was significantly different (p < 0.05) 
from the relative fitness distribution of the remaining sgRNAs targeting the gene. If their 
distribution was significantly different and their mean relative fitness was higher than the 
other sgRNAs targeting the same gene, we surmised that the fully matched sgRNA was 
likely not functional and excluded its series from further analysis.  
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2. We next predicted the sgRNA activity of all sgRNAs using the model of sgRNA efficacy 
described above trained on the two species averaged GFP data also described above. 
Consistent with the definition of sgRNA activity above, fully complementary sgRNAs were 
assigned an sgRNA activity of 1.  
3. We binned sgRNAs that passed our filter (Step 1) based on their predicted sgRNA activity 
(bin width = 0.2, bin spacing = 0.05, for a total of 17 bins), and within each bin we calculated 
the median relative fitness. A fully healthy (relative fitness = 1, predicted sgRNA activity = 0) 
pseudocount was included for each gene. Per gene bin medians for essential genes can be 
found in Tables S5.  
 
Per gene bin medians were used in all analyses of gene expression-fitness relationship 
similarity.  
 
Per gene and per sgRNA family correlation 
For both E. coli and B. subtilis, per sgRNA family correlations were calculated for sgRNA 
families that passed the filter described above, had at least one relative fitness value less than 
0.7, and had measurements for at least 6/10 possible sgRNAs. Similarly, per gene correlations 
for genes with a last bin fitness less than 0.7 and computed using sgRNA families that passed 
the filter described above. 
 
Gene expression-fitness relationship clustering and enrichment analysis 
To determine whether per gene expression-fitness curves were biologically meaningful, we 
clustered the bin medians (described above) for all essential gene in E. coli and B. subtilis into 9 
clusters using k-means with 10,000 random restarts. Functional enrichment within clusters was 
calculated for COG categories, GO biological process terms, and KEGG terms using the 
hypergeometric test. Only p-values with Bonferroni corrected (p < 0.05) are shown in Table S6.   
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Gene similarity comparisons 
To determine whether the expression-fitness relationships of genes within COG categories, GO 
biological process, or KEGG categories were more similar to each other than to those of other 
genes we first calculated pairwise Euclidean distances between the expression-fitness 
relationships of all essential genes within each species. We then used a two-sided t-test to 
compare the distances between genes within each category to the distances between those 
genes and genes in different categories. We accounted for CRISPRi polarity due to operon 
structure by excluding any distances between genes within the same operon (defined as two 
genes in the same direction <50bp apart) from both the “inside category” and the “outside 
category” set. 
To determine whether the expression-fitness relationships of homologous genes were 
more similar to each other than to those of other genes in the opposing organism, we calculated 
the pairwise Euclidean distance between the expression-fitness relationships of all essential 
genes that have essential homologs in both E. coli and B. subtilis (n = 150, as defined in Koo et 
at., 2017). We next used a two-sided t-test to determine if the distance between homologs was, 
on average, different from the overall distribution of distances between these 150 genes (i.e. 
when one gene from one species is compared to the 149 genes in the opposing species). To 
determine which pairs of homologs were significantly dissimilar, for each gene pair (including 
homologs), we calculated how many cross-species comparisons involving either gene were 
more similar than the comparison in question. We compared this number in homologs and non-
homologs to calculate a FDR.   
 
Quantification and statistical analysis: 
Statistical parameters—including r, R2, SD—are reported in the Figures, Figure Legends, or 
Supplementary Tables, as indicated and described in Methods Details (above). 
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Data and code availability: 
Data 
All raw sequencing data is deposited in the Short Read Archive under accession 
PRJNA574461.  
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FIGURES 
 
 
 
Figure 3.1. Singly mismatched sgRNAs reproducibly generate a range of knockdown efficacies 
in B. subtilis and E. coli but perform differently from a dCas9-KRAB system in mammalian cells. 
(A) Workflow of a FACS-seq experiment. (B) FACS-seq scores (average of 2 biological 
replicates) for each singly mismatched sgRNA targeting gfp in B. subtilis and E. coli. Additional 
noise in E. coli likely represents changes in plasmid copy number during outgrowth. (C) Mean 
relative activity of sgRNAs with all possible single base substitutions at every possible position 
in E. coli and B. subtilis targeting gfp data and in a mammalian CRISPRi system targeting 
essential genes (Jost et al., 2020), total of 26,248 mismatched sgRNAs) 
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Figure 3.2. Mismatched sgRNA activity is accurately predicted by a simple linear model. (A) 
Schematic representation of a simple linear model for predicting the relative activity of 
mismatched sgRNAs. (B) Distributions of singly mismatched sgRNA relative activities by 
mismatch position. Each distribution represents 36-93 sgRNAs. (C) Comparison of model 
parameters for base substitution and the average ΔΔG of the mismatch calculated using a 
nearest neighbor approximation and the values from (Alkan et al., 2018). (D) The predictions of 
a linear model trained on GC%, mismatch position, and mismatch identity compared to the 
measured relative gfp knockdown efficacies of each sgRNA averaged over both species. Inset 
is a histogram of the differences between predicted and measured knockdown, reflecting both 
prediction and measurement error: 56% of sgRNAs measured within 0.15 of their predicted 
activity (red bars). (E) The predictions of the linear model compared to the measured singly 
mismatched sgRNA association rates (kON) in vitro (Boyle et al., 2017). Grey lines indicate the 
average (solid) and average +/- 1 SD (dashed) association rate of sgRNAs with mutated PAMs. 
Since such sgRNAs have no measurable association rate, this represents the detection limit of 
the assay in (Boyle et al., 2017).  
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Figure 3.3. The expression-fitness curves of essential genes in E. coli and B. subtilis can be 
studied using singly mismatched sgRNAs. (A) Schematic of the fitness experiment design. (B) 
Distribution of per sgRNA locus (solid lines) and per gene (dashed lines) correlations (Pearson 
r) for sgRNAs targeting genes in E. coli (orange) and B. subtilis (blue). (C-D) The fitness effects 
of all fully complementary sgRNA targeting essential genes in E. coli (C) and B. subtilis (D) 
showing that the identity of the targeted gene is the driving factor in determining the fitness 
effect of an sgRNA. Genes are arranged in order of median fitness defect.  
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Figure 3.4. Expression-fitness relationships of essential genes are conserved within biological 
process and between B. subtilis and E. coli. Relative fitness compared to predicted knockdown 
for: essential cofactor biosynthesis genes (KEGG pathways under “Metabolism of cofactors and 
vitamins”) in B. subtilis (A) or E. coli (B); KEGG pathways under “Translation” in B. subtilis (C) or 
E. coli (D); peptidoglycan biosynthesis (KEGG pathway ko00550) in B. subtilis. (E) or E. coli (F). 
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Figure 3.5. Similar and different expression-fitness relationships of cell wall biosynthesis genes 
in B. subtilis and E. coli. (A) Pathway of peptidoglycan synthesis and incorporation, color coded 
by portion of the pathway. (B) Predicted knockdown vs. relative fitness for the groups of 
essential genes from pathway sections indicated in (A), in B. subtilis and E. coli. 
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Figure 3.6. Screening mismatched sgRNA libraries in combination with genetic perturbations 
reveals modulators of essential gene requirements. (A) RT-qPCR measurements of repression 
by sgRNAs targeting 4 essential genes in E. coli shows that both mismatched and fully 
complementary sgRNAs are able to repress transcription. (B) Schematic of peptidoglycan 
recycling and synthesis pathway in E. coli. (C-D) Volcano plots comparing the median change in 
relative fitness for all sgRNAs targeting a gene to the statistical significance of those changes as 
quantified by a Wilcox test in the ΔampG (C) and Δmpl (D) genetic backgrounds. The dashed 
line represents a Bonferroni corrected p-value < 0.01  
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Figure 3.7. Environmental changes can modulate essential gene requirements. (A) Schematic 
of dihydrofolate reductase (dfrABsu) inhibition by trimethoprim. (B) Expression fitness curve of B. 
subtilis dfrA in LB (black), LB+15ng/ml trimethoprim (red), and LB+30ng/ml trimethoprim 
(purple) showing the expression dependent synergy between DfrA depletion and trimethoprim.   
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Figure 3.8. Design of mismatched sgRNA libraries targeting (A) gfp, (B) comprehensive 
libraries targeting dfrA, folA, murAA, and murA, and (C) each essential gene for the large 
libraries and the compact libraries. The breakdown of single mismatch variants per series and 
the total unique sgRNAs per gene are shown for each. 
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Figure 3.9. Details related to the linear model, FACS-seq data, and its validation. (A) 
Mismatched sgRNA efficacy measured individually (relative GFP fluorescence) in either E. coli 
or B. subtilis compared to their FACS-seq score from measurements done in the same species. 
Relative fluorescence is the median GFP single-cell fluorescence, normalized as a fraction of 
non-targeted control. (B) FACS-seq scores for all sgRNAs comparing two biological replicates in 
B. subtilis. (C) FACS-seq scores for all sgRNAs comparing two biological replicates in E. coli. 
Increased noise in E. coli likely reflects variation in sgRNA plasmid copy number at the time of 
 123 
DNA extraction and/or sequence-based E. coli specific effects on sgRNA efficacy (Cui et al., 
2018). (D) Schematic describing the isolation of random singly mismatched sgRNA strains from 
the E. coli gfp library, their analysis by flow cytometry, the introduction of the same sgRNA 
plasmids into B. subtilis, and their analysis by flow cytometry. (E-F) The distribution of single-cell 
GFP fluorescence values for strains of E. coli (E) or B. subtilis (F). (G) The sequences of the 
spacers indicated in (E) and (F), with mismatched bases highlighted in red. 
  
 124 
 
 
 
Figure 3.10. Doubly mismatched sgRNAs are accurately predicted as the combined 
independent effects of singly mismatched sgRNAs. (A) FACS-seq enrichment scores (average 
of 2 biological replicates) for each doubly mismatched sgRNA targeting gfp in B. subtilis and E. 
coli.  (B) The predictions of the linear model for doubly mismatched sgRNA efficacy, treating 
each mismatch as independently affecting sgRNA efficacy, compared to the doubly mismatched 
sgRNAs’ measured gfp knockdown efficacies (two species averages). (C) The predictions of the 
linear model for doubly mismatched sgRNAs compared to the measured doubly mismatched 
sgRNA association rates (kON) in vitro (Boyle et al., 2017). Grey lines indicate the average 
(solid) and average +/- 1 SD (dashed) association rate of sgRNAs with mutated PAMs. Since 
such sgRNAs have no measurable association rate, this represents the detection limit of the 
assay in (Boyle et al., 2017).  
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Figure 3.11. Mismatched sgRNAs affect CRISPRi efficacy similarly in mammalian systems and 
bacterial systems. (A) The mean relative activity of sgRNAs targeting essential mammalian 
genes with specific base substitutions at specific positions. Mismatches at position 20 are not 
shown because all sgRNAs contained a “G” at position 20 for compatibility with the U6 
promoter. (B) The species-averaged mean relative activity of sgRNAs targeting gfp in E. coli 
and B. subtilis with specific base substitutions at specific positions. Darker color indicates 
stronger sgRNA activity. (C) Comparison of the species-averaged mean relative activity of 
sgRNAs targeting gfp in E. coli and B. subtilis with specific base substitutions at specific 
positions and the relative activity of singly mismatched sgRNAs targeting gfp in a mammalian 
system (Jost et al., 2020). Mismatch effect is correlated (R2 = 0.44, p < 10-7), but non-linear.  
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Figure 3.12. Parameters of linear models of singly mismatched sgRNA efficacy trained on 
FACS-seq or relative fitness data from either E. coli or B. subtilis have strongly correlated 
coefficient values. Each panel compares the coefficient values from the linear models trained on 
the two specified datasets.  
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Figure 3.13. Linear models of singly mismatched sgRNA efficacy trained on FACS-seq or 
relative fitness data from E. coli, B. subtilis, or the average of both (averaged gfp) retain a 
majority of their predictive power on other singly mismatched sgRNA datasets. Each panel 
compares the predictions of a linear model trained on the specified dataset to the measured 
efficacy (relative fitness or FACS-seq score) of sgRNAs in the other specified dataset, with the 
pearson correlation coefficient shown in the inset. The datasets used and evaluated are, in 
order from top-bottom and left-to-right: species averaged gfp, E. coli gfp, B. subtilis gfp, E. coli 
folA, and B. subtilis dfrA.   
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Figure 3.14. Relative fitness measurements are reproducible, orthogonally validated, and 
capture a large dynamic range. (A-B) Relative fitness measurements from two biological 
replicates in E. coli (A), and B. subtilis (B). (C) Relative fitness from pooled experiment 
compared to a relative fitness metric from competing individual dfrA-targeting CRISPRi strains 
against a fluorescently labeled wildtype and enumerating their relative abundance by flow 
cytometry before and after 10 doublings. (D & E) Per sgRNA relative fitness compared to 
previously reported fitness measurements (Rousset et al., 2018; Wang et al., 2018) showing the 
increased dynamic range of our measurements. The minimum quantifiable relative fitness can 
be approximated by the log2(median per sgRNA read count) divided by number of generations 
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of growth. In (Wang et al., 2018), median read count per sgRNA was ~100, and strains were 
grown for ~15 generations; therefore, relative fitness below ~0.6 is not resolvable. Similarly, in 
(Rousset et al., 2018), median read count per sgRNA was >200 (~17 million total counts, 
92,919 elements), and strains were grown for ~17 generations; therefore, relative fitness below 
0.6 is not resolvable.  
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Figure 3.15. Fully complementary sgRNA efficacy is not significantly correlated with distance 
within the open reading frame in E. coli or in B. subtilis. (A-B) sgRNA distance from gfp ATG 
compared to its FACS-seq score in E. coli (A) and B. subtilis (B). (C) sgRNA distance from folA 
ATG compared to its impact on fitness in E. coli. (D) sgRNA distance from dfrA ATG compared 
to its impact on fitness in B. subtilis.  
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Figure 3.16. Singly mismatched sgRNAs targeting E. coli murA and B. subtilis murAA generate 
bimodal phenotypes that are not due to bimodal knockdown activity. (A-B) Predicted sgRNA 
activity and measured relative fitness of singly mismatched sgRNA targeting: (A) murAA in B. 
subtilis. (B) murA in E. coli. (C-D) Histogram of fitness outcomes for the same sgRNAs (E) 
Predicted sgRNA activity and relative expression for 18 singly mismatched sgRNA targeting a 
murAA-gfp transcriptional fusion in a murAA–complemented B. subtilis strain (Methods). 
Relative expression is shown as the median single-cell GFP fluorescence, normalized as a 
fraction of control (no sgRNA).  
 
  
 132 
 
 
 
Figure 3.17. Design constraints and measured efficacy of singly mismatched sgRNAs in the 
compact libraries. (A) Confusion matrix showing the singly mismatched sgRNAs selected for the 
compact library based on their predicted knockdown vs. their measured relative fitness in E. 
coli. Designed relative fitness shows the predicted knockdown normalized by the strongest 
efficacy sgRNA’s relative fitness. (B) Same as (A) for the compact library in B. subtilis. 
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TABLES 
 
Table 3.1. Key resources 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Chemicals, Peptides, and Recombinant Proteins 
Lysogeny broth (LB), Lennox Fisher scientific Cat# BP1427-2 
Bacillus subtilis MC medium Koo et al., 2017 N/A 
Bacillus subtilis competence medium Koo et al., 2017 N/A 
IPTG Denville scientific Cat# C18280-13 
Xylose   
Ampicillin sodium salt Sigma-Aldrich Cat# A9518 
Kanamycin sulfate 
 
Sigma-Aldrich Cat# K1377 
Erythromycin 
 
Sigma-Aldrich Cat# E5389 
Spectinomycin dihydrochloride pentahydrate 
 
Sigma-Aldrich Cat# S9007 
Chloramphenicol Sigma-Aldrich Cat# C0378 
Carbenicillin Millipore-Sigma Cat# 205805 
Gentamicin sodium salt Fisher Scientific Cat# AAJ1605103 
Trimethoprim Sigma-Aldrich Cat# T7883-5G 
   
Q5 High-Fidelity DNA polymerase 
 
New England 
Biolabs 
 
Cat# M0493S 
 
HiFi Assembly New England 
Biolabs 
 
Cat# E2621L 
BsaI-HFv2 New England 
Biolabs 
Cat# R3733 
T4 DNA Ligase New England 
Biolabs 
Cat# M0202L 
Critical Commercial Assays 
DNeasy Blood & Tissue Kit 
 
Qiagen 
 
Cat# 69506 
 
Midiprep Kit Qiagen Cat# 12143 
QIAprep Spin miniprep kit Qiagen Cat# 27106 
Deposited Data 
Raw sequencing data (FASTQs) for relative fitness 
experiments and FACS-seq experiments 
This study SRA: 
PRJNA574461 
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REAGENT or RESOURCE SOURCE IDENTIFIER 
Experimental Models: Organisms/Strains 
Bacillus subtilis 168 BGSC 
 
1A1 
 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm) Peters et al., 2016 CAG74209 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
amyE::Pveg-sgRNA(cat) (CRISPRi libraries: 
sgRNA spacers listed in Table S3) 
This study N/A 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
thrC::Pveg-gfp(Spc) 
This study CAG78920 
 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
thrC::Pveg-gfp(Spc), pJSHA77 (CRISPRi libraries: 
sgRNA spacers listed in Table S1) 
This study N/A 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
thrC::Pveg-rfp(Spc) 
This study CAG78921 
 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
thrC::Pveg-rfp(Spc), pJSHA77 (CRISPRi libraries: 
sgRNA spacers listed in Table S1) 
This study N/A 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
sacA::Pveg-rfp 
This study CAG78922 
 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
sacA::Pveg-rfp, murAA-gfp(Kan) 
This study CAG78923 
 
Bacillus subtilis 168 lacA::Pxyl-dcas9(Erm), 
sacA::Pveg-rfp, murAA-gfp(Kan), thrC::Pveg-
murAA*(Spc) 
This study CAG78924 
 
Escherichia coli BW25113 Baba et al., 2006 
 
N/A 
Escherichia coli BW25113 Tn7att::PlLac-O1-
dcas9(Gent) 
This study CAG78830 
Escherichia coli BW25113 Tn7att::PlLac-O1-
dcas9(Gent), pJSHA77 (CRISPRi libraries: sgRNA 
spacers listed in Table S3) 
This study N/A 
Escherichia coli BW25113 Tn7att::PBBa_J23105-
dcas9(Gent), yjaA:Pveg-gfp(Cat):yjaB 
This study CAG78108 
Escherichia coli BW25113 Tn7att::PBBa_J23105-
dcas9(Gent), yjaA:Pveg-gfp(Cat):yjaB, pJSHA77 
(CRISPRi libraries: sgRNA spacers listed in Table 
S1) 
This study N/A 
Escherichia coli BW25113 Tn7att::PBBa_J23105-
dcas9(Gent), yjaA:Pveg-rfp(Cat):yjaB 
This study CAG78107 
Escherichia coli BW25113 Tn7att::PBBa_J23105-
dcas9(Gent), yjaA:Pveg-rfp(Cat):yjaB, pJSHA77 
(CRISPRi libraries: sgRNA spacers listed in Table 
S1) 
This study N/A 
10-beta Electrocompetent Escherichia coli New England 
Biolabs 
Cat# C3020K 
Oligonucleotides 
Primers used in this study are listed in Table S8 This study N/A 
Recombinant DNA 
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REAGENT or RESOURCE SOURCE IDENTIFIER 
pDG1731 Radeck et al., 2013 pBS4S (Addgene# 
55170) 
pDG1731-gfp This study N/A 
pDG1731-rfp This study N/A 
pDG1622 BGSC ECE119 
pJSHA77 This study N/A 
pJSHA77-rfp This study N/A 
pJSHA77-gfp This study N/A 
   
Software and Algorithms 
Bowtie2 Langmead and 
Salzberg, 2012 
 
http://bowtie-
bio.sourceforge.ne
t/bowtie2/index.sht
ml 
 
sgRNA design (fully matched sgRNAs) This study https://github.co
m/traeki/sgrna_d
esign 
Linear model training (train_linear_model.py) This study https://github.co
m/traeki/mismatc
h_crispri 
Design a subset of mismatch sgRNA 
(choose_guides.py) 
This study https://github.co
m/traeki/mismatc
h_crispri 
FASTQ analysis to calculate sgRNA abundance 
and relative fitness (count_guides.py, 
compute_gammas.py, gamma_to_relfit.py) 
This study https://github.co
m/traeki/mismatc
h_crispri 
FlowJo v10 FlowJo, LLC  
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